<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>European Archives of Psychiatry and Clinical Neuroscience via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'European Archives of Psychiatry and Clinical Neuroscience' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=European+Archives+of+Psychiatry+and+Clinical+Neuroscience&t=European+Archives+of+Psychiatry+and+Clinical+Neuroscience&s=Search&f=source]]></link>
        <lastBuildDate>Tue, 07 Feb 2012 07:05:42 +0100</lastBuildDate>
        <item>
            <title>Substance abuse and suicide risk among adolescents</title>
            <link>http://www.medworm.com/index.php?rid=5657866&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F72273429755m3674%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this paper was to review the literature concerning the relationship between suicide and substance abuse behaviours
 among adolescents, focusing on epidemiology, comorbidity and preventive programmes. We performed a Pubmed/Medline, Scopus,
 PsycLit and PsycInfo search to identify all papers and book chapters during the period between 1980 and 2011. Adolescents
 with substance abuse disorder who attempt or complete suicide can be characterized as having mood disorders, stressful life
 events, interpersonal problems, poor social support, lonely lives and feelings of hopelessness. The research supports the
 existence of a strong relationship between suicide and substance abuse. Preventive programmes should be based on the detection
 of risk factors associated wit...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5657866</comments>
            <pubDate>Mon, 30 Jan 2012 16:07:15 +0100</pubDate>
            <guid isPermaLink="false">5657866</guid>        </item>
        <item>
            <title>Efficacy of bifocal diagnosis-independent group psychoeducation in severe psychiatric disorders: results from a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5657867&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnlr3p66x48774351%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite evidence for its efficacy, diagnosis-specific psychoeducation is not routinely applied. This exploratory randomized
 controlled trial analyses the efficacy of an easily implementable bifocal diagnosis-mixed group psychoeducation in the treatment
 of severe psychiatric disorders regarding readmission, compliance and clinical variables, for example global functioning.
 Inpatients of the Psychiatric Hospital of the University of Basel (N&amp;nbsp;=&amp;nbsp;82) were randomly assigned to a diagnosis-mixed psychoeducational (PE) or a non-specific intervention control group. Relatives
 were invited to join corresponding family groups. Results at baseline, 3- and 12-month follow-ups are presented. Better compliance
 after 3&amp;nbsp;months and a lower suicide rate were significant...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5657867</comments>
            <pubDate>Mon, 30 Jan 2012 16:07:14 +0100</pubDate>
            <guid isPermaLink="false">5657867</guid>        </item>
        <item>
            <title>SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5645043&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw51448715321x741%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The neuronal sortilin-related receptor with A-type repeats (SORL1, also called LR11 or sorLA) is involved in amyloidogenesis,
 and the SORL1 gene is a major risk factor for Alzheimer’s disease (AD). We investigated AD-related CSF biomarkers for associations with
 SORL1 genetic variants in 105 German patients with mild cognitive impairment (MCI) and AD. The homozygous CC-allele of single nucleotide
 polymorphism (SNP) 4 was associated with increased Tau concentrations in AD, and the minor alleles of SNP8, SNP9, and SNP10
 and the haplotype CGT of these SNPs were associated with increased SORL1 concentrations in MCI. SNP22 and SNP23, and the haplotypes
 TCT of SNP19-21-23, and TTC of SNP22-23-24 were correlated with decreased Aβ42 levels in AD. These results strengthen...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5645043</comments>
            <pubDate>Fri, 27 Jan 2012 17:55:12 +0100</pubDate>
            <guid isPermaLink="false">5645043</guid>        </item>
        <item>
            <title>Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospital</title>
            <link>http://www.medworm.com/index.php?rid=5636682&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg743n1374g030p46%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In 2006 and 2007, around 0.4 and 0.7% of all German soldiers involved in missions abroad were registered as suffering from
 PTSD. The frequency of PTSD in the German Armed Forces was assessed from army records. All soldiers admitted to the German
 Military Hospital in Hamburg, Germany, with PTSD (n&amp;nbsp;=&amp;nbsp;117) in the years 2006 and 2007 were assessed by using questionnaires and structure interviews. Risk factors associated
 with PTSD were identified. Of the 117 soldiers with PTSD, 39.3% were in missions abroad, and 18.0% had participated in combat
 situations. Five (4.3%) were wounded in combat, and 4 of them had a serious irreversible injury. In total, 53.8% of the PTSD
 cases were related to injuries or physical/sexual abuse, while 46.2% were due to psychological...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636682</comments>
            <pubDate>Tue, 24 Jan 2012 12:26:03 +0100</pubDate>
            <guid isPermaLink="false">5636682</guid>        </item>
        <item>
            <title>Standardized diagnostic interviews, criteria, and algorithms for mental disorders: garbage in, garbage out</title>
            <link>http://www.medworm.com/index.php?rid=5636683&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp3l9396717651692%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is a general consensus that diagnoses for mental disorders should be based on criteria and algorithms as given in ICD
 or DSM. Standardized clinical interviews are recommended as diagnostic methods. In ICD and DSM, much emphasis is put on algorithms,
 while the underlying criteria get much less attention. The question is how valid are the criteria that are collected by structured
 diagnostic interviews. 209 patients from a cardiology inpatient unit were interviewed with the Mini International Neuropsychiatric Interview (MINI). 32 (15.3%) were diagnosed as suffering from a major depressive episode or dysthymia. Additionally, a thorough clinical
 examination was done by a psychiatric expert in 15 patients. The standardized diagnosis of present major depression was r...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636683</comments>
            <pubDate>Tue, 24 Jan 2012 12:26:01 +0100</pubDate>
            <guid isPermaLink="false">5636683</guid>        </item>
        <item>
            <title>Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6</title>
            <link>http://www.medworm.com/index.php?rid=5636684&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx5r6446t53757210%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several studies have shown an involvement of the immune system, in particular the monocytic system, in the pathophysiology
 of schizophrenia. Beside others, the monocyte-derived cytokines TNF-α, IL-6 and IL-10 were found to be affected. Since cytokines
 are secreted by several different cell types, the cellular source is only clear if intracellular levels are measured. Thus,
 in order to study the monocytic system in schizophrenia, the intracellular levels of TNF-α, IL-6 and IL-10 were determined.
 The intracellular concentration of TNF-α, IL-6 and IL-10 in CD33 positive monocytes was evaluated in schizophrenic patients
 and controls with monoclonal antibodies against these cytokines. In addition, in vitro stimulation with lipopolysaccharide
 (LPS) or poly I/C, which...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636684</comments>
            <pubDate>Tue, 24 Jan 2012 07:34:45 +0100</pubDate>
            <guid isPermaLink="false">5636684</guid>        </item>
        <item>
            <title>Neurobiology of schizophrenia: from outcome to pathophysiological insights</title>
            <link>http://www.medworm.com/index.php?rid=5636685&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl714w37557868513%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00406-012-0294-yAuthors
		P. Falkai, Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, GermanyH. -J. Möller, Department of Psychiatry, Ludwigs-Maximililans-University Munich, Nussbaumstr. 7, 80336 Munich, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636685</comments>
            <pubDate>Tue, 24 Jan 2012 07:34:41 +0100</pubDate>
            <guid isPermaLink="false">5636685</guid>        </item>
        <item>
            <title>On the application of light therapy in German-speaking countries</title>
            <link>http://www.medworm.com/index.php?rid=5579028&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh20hn5732155w862%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Many studies have investigated seasonal affective disorder (SAD; fall-winter-depression) and its treatment with light therapy
 (LT). However, to the best of our knowledge, no other study has investigated the usage of LT in Europe since 1994. Thus, we
 performed a survey in hospitals with adult psychiatric departments in German-speaking countries by questionnaire. First, a
 questionnaire was constructed, considering also recent developments in LT. This questionnaire was sent to all hospitals with
 adult psychiatric departments listed in the “Deutsches Krankenhaus Adressbuch,” which contains hospitals from all German-speaking
 countries (Germany, Switzerland, and Austria). Non-responders were asked to answer the questionnaire by mail and by phone.
 We achieved a compl...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579028</comments>
            <pubDate>Fri, 06 Jan 2012 16:47:34 +0100</pubDate>
            <guid isPermaLink="false">5579028</guid>        </item>
        <item>
            <title>Ethics of clinical research with mentally ill persons</title>
            <link>http://www.medworm.com/index.php?rid=5570395&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F253230x05n486150%2F</link>
            <description>This article describes ethical, legal and professional components of the two core requirements of clinical research: informed consent and risk–benefit relationships. It deals particularly
 with the ethically relevant reasons, criteria, procedures and validity of (1) the informed consent process, (2) the relationship
 between benefits and risks, and as a requirement of its assessment: (3) standards and (quasi quantitative) criteria of benefits
 and risks and/or burdens of a research intervention. These requirements will be discussed with specific reference to research
 interventions in mentally ill patients, and particularly in those who are incompetent to consent. (4) The analysis concludes
 by demanding a strong adherence to the ethical rules of clinical research in order to protect par...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5570395</comments>
            <pubDate>Mon, 02 Jan 2012 16:53:19 +0100</pubDate>
            <guid isPermaLink="false">5570395</guid>        </item>
        <item>
            <title>A new rating scale for adult ADHD based on the Symptom Checklist 90 (SCL-90-R)</title>
            <link>http://www.medworm.com/index.php?rid=5570394&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj230j7u5x541184u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Attention deficit hyperactivity disorder (ADHD) in adults is increasingly recognized as a clinically important syndrome. The
 aim of this study was to evaluate the psychometric performance of a new scale for adult ADHD based on the widely used Symptom
 Checklist 90 Revised (SCL-90-R). Scale performance was assessed in a clinical study including 100 ADHD patients and 65 opiate-dependent
 patient controls, and in the Zurich study, an epidemiological age cohort followed over 30&amp;nbsp;years of adult life. Assessments
 included a ROC analysis of sensitivity and specificity, internal consistency, test–retest reliability, external validity and
 measurement invariance over nine testing occasions. The new scale showed a sensitivity and specificity of 75 and 54%, respectively,
 ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5570394</comments>
            <pubDate>Mon, 02 Jan 2012 16:53:19 +0100</pubDate>
            <guid isPermaLink="false">5570394</guid>        </item>
        <item>
            <title>Response rate of catatonia to electroconvulsive therapy and its clinical correlates</title>
            <link>http://www.medworm.com/index.php?rid=5557382&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F95346344764103p0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Electroconvulsive therapy (ECT) is an important treatment for catatonia. We aimed to study the response rate of catatonia
 treated with ECT and its clinical correlates in a large sample of inpatients. The ECT parameters of all patients (n&amp;nbsp;=&amp;nbsp;63) admitted with catatonia between the months of January and December 2007 were examined. The number of ECTs administered,
 seizure threshold, failure to achieve adequate seizures and clinical signs pertaining to catatonia were analyzed. Response
 was considered as complete resolution of catatonic symptoms with Bush Francis Catatonia Rating Scale (BFCRS) score becoming
 zero. ECT was mostly started after failed lorazepam treatment except in 6 patients where ECT was the first choice. Patients
 who responded in 4 ECT session...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5557382</comments>
            <pubDate>Fri, 30 Dec 2011 07:08:56 +0100</pubDate>
            <guid isPermaLink="false">5557382</guid>        </item>
        <item>
            <title>Emotional status: diagnosis and treatment for severe psychiatric disorders</title>
            <link>http://www.medworm.com/index.php?rid=5557383&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3312h16w73408846%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00406-011-0284-5Authors
		P. Falkai, Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, GermanyH.-J. Möller, Psychiatry Hospital, Ludwigs-Maximililans-University Munich, Nussbaumstr. 7, 80336 Munich, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5557383</comments>
            <pubDate>Tue, 27 Dec 2011 17:03:27 +0100</pubDate>
            <guid isPermaLink="false">5557383</guid>        </item>
        <item>
            <title>Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency</title>
            <link>http://www.medworm.com/index.php?rid=5542897&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr712243814506jx3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The N-methyl-d-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. Administered to healthy individuals,
 a subanesthetic dose of the noncompetitive NMDAR antagonist ketamine reproduces several psychopathological symptoms commonly
 observed in patients with schizophrenia. In a counterbalanced, placebo-controlled, double-blind, within-participants study, fifteen healthy subjects were administered a continuous subanesthetic
 S-ketamine infusion while cortical activation was measured using functional magnetic resonance imaging. While being scanned,
 subjects performed an overt word generation task. Ketamine-induced psychopathological symptoms were assessed with the Positive
 and Negative Syndrome Scale (PANSS). Ketamine administration eli...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5542897</comments>
            <pubDate>Wed, 21 Dec 2011 20:07:52 +0100</pubDate>
            <guid isPermaLink="false">5542897</guid>        </item>
        <item>
            <title>Prevalence of the metabolic syndrome in unipolar major depression</title>
            <link>http://www.medworm.com/index.php?rid=5535247&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb042714327063576%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Previous studies on the association between affective disorders and the metabolic syndrome yielded inconclusive results. Therefore,
 we examined the prevalence of the metabolic syndrome in 230 men and women with unipolar major depressive disorder during inpatient
 treatment and compared it to 1,673 subjects from primary care from a similar region in northern Germany. We used the AHA/NHBLI
 criteria to determine the rate of metabolic syndrome (MetS) and each single criterion of MetS in both groups. The age-standardized
 prevalence of MetS was 2.4×&amp;nbsp;as high in patients with major depressive disorder (MDD) compared with data from comparison subjects
 (41.0% vs. 17.0%). With respect to the single criteria, elevations were found in MDD patients for fasting glucose and t...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5535247</comments>
            <pubDate>Mon, 19 Dec 2011 16:49:52 +0100</pubDate>
            <guid isPermaLink="false">5535247</guid>        </item>
        <item>
            <title>Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?</title>
            <link>http://www.medworm.com/index.php?rid=5521722&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9016pt6q4112g20n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Here, we review the cerebrospinal fluid (CSF) candidate markers with regard to their clinical relevance as potential surrogates
 for disease activity, prognosis assessment, and predictors of treatment response. We searched different online databases such
 as MEDLINE and EMBASE for studies on schizophrenia and CSF. Initial studies on cerebrospinal fluid in patients with schizophrenia
 revealed increased brain–blood barrier permeability with elevated total protein content, increased CSF-to-serum ratio for
 albumin, and intrathecal production of immunoglobulins in subgroups of patients. Analyses of metabolites in CSF suggest alterations
 within glutamatergic neurotransmission as well as monoamine and cannabinoid metabolism. Decreased levels of brain-derived
 neurotrophic...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5521722</comments>
            <pubDate>Thu, 15 Dec 2011 16:49:53 +0100</pubDate>
            <guid isPermaLink="false">5521722</guid>        </item>
        <item>
            <title>Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients</title>
            <link>http://www.medworm.com/index.php?rid=5513564&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm2729w8g5k414750%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-3DOI 10.1007/s00406-011-0283-6Authors
		Julian A. J. Jaros, Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QT UKDaniel Martins-de-Souza, Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QT UKHassan Rahmoune, Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QT UKEmanuel Schwarz, Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QT UKF. Markus Leweke, Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, GermanyPaul C. Guest, Department of Chemical...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5513564</comments>
            <pubDate>Wed, 14 Dec 2011 16:42:02 +0100</pubDate>
            <guid isPermaLink="false">5513564</guid>        </item>
        <item>
            <title>Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis</title>
            <link>http://www.medworm.com/index.php?rid=5513565&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp8335374253jn781%2F</link>
            <description>In conclusion, apart from beneficial effects on synaptic plasticity and neurogenesis, VGF may be linked to schizophrenia-related
 alterations in energy homeostasis.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-10DOI 10.1007/s00406-011-0282-7Authors
		Stefan Busse, Department of Psychiatry, University of Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, GermanyHans-Gert Bernstein, Department of Psychiatry, University of Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, GermanyMandy Busse, Department of Pediatric Pulmonology and Allergology, Medical University of Hannover, Hannover, GermanyHendrik Bielau, Department of Psychiatry, University of Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, GermanyRalf Brisch, Department of Psychiatry, University of Magdeburg, Leipziger...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5513565</comments>
            <pubDate>Tue, 13 Dec 2011 17:05:00 +0100</pubDate>
            <guid isPermaLink="false">5513565</guid>        </item>
        <item>
            <title>Effects of media reports and the subsequent voluntary withdrawal from sale of suicide-related products on the suicide rate in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5474509&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd3466143j203l686%2F</link>
            <description>We examined the association between media reports of suicides accomplished with the use of hydrogen sulfide, the voluntary
 stoppage of sales of suicide-related products, and suicide rates for people in their 20s, 30s, and 40s in Japan. The Box-Jenkins
 transfer function model was applied to monthly time series data from February 2003 to December 2009 (83&amp;nbsp;months). In the male
 suicide time series, media reports of suicide were not related to suicide counts (ω(R)&amp;nbsp;=&amp;nbsp;8.988, P&amp;nbsp;=&amp;nbsp;0.694). Similarly, stopping the sale of bath salts was not related to the number of suicides (ω(S)&amp;nbsp;=&amp;nbsp;−7.344, P&amp;nbsp;=&amp;nbsp;0.694). However, in the female suicide time series, media reports of suicide were related to the number of suicides (ω(R)&amp;nbsp;=&amp;nbsp;17.225, P&amp;nbsp;=&amp;nbsp;0...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5474509</comments>
            <pubDate>Fri, 02 Dec 2011 18:09:47 +0100</pubDate>
            <guid isPermaLink="false">5474509</guid>        </item>
        <item>
            <title>Case–control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics</title>
            <link>http://www.medworm.com/index.php?rid=5466651&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc1878g1826t20512%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study is to investigate possible associations between a set of single-nucleotide polymorphisms (SNPs) within
 10 genes with Schizophrenia (SCZ) and response to antipsychotics in Korean in-patients treated with antipsychotics. Two hundred
 and twenty-one SCZ in-patients and 170 psychiatrically healthy controls were genotyped for 42 SNPs within ABCB1, ABCB4, TAP2,
 CLOCK, CPLX1, CPLX2, SYN2, NRG1, 5HTR1A and GPRIN2. Baseline and final clinical measures, including the Positive and Negative
 Symptoms Scale (PANSS), were recorded. Rs10042486 within 5HTR1A was associated with both SCZ and clinical improvement on PANSS
 total scores as well as on PANSS positive and PANSS negative scores. The haplotype analyses focusing on the four, three and
 two blocks’ hapl...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5466651</comments>
            <pubDate>Sat, 26 Nov 2011 16:47:36 +0100</pubDate>
            <guid isPermaLink="false">5466651</guid>        </item>
        <item>
            <title>The interrelation of needs and quality of life in first-episode schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=5455203&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F045121v077426437%2F</link>
            <description>This study relied on data from the EUFEST trial,
 designed to compare first- and second-generation antipsychotics during 1&amp;nbsp;year. At baseline, 498 patients have been included.
 The first (baseline) and the last assessment (12&amp;nbsp;months after baseline) were used for the analyses. Predictors of quality
 of life were determined using regression analyses. We tested the complex longitudinal interrelations between baseline and
 outcome measures with structural equation models. Unmet needs were not definitively confirmed as a predictor of subsequent
 quality of life, unless unmet needs changing to no needs were separated from unmet needs changing to met needs. Each unmet
 need that changed to no need enhanced the quality of life (mean score 1–7) by 0.136 scale points. This study suggests ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5455203</comments>
            <pubDate>Wed, 23 Nov 2011 17:37:32 +0100</pubDate>
            <guid isPermaLink="false">5455203</guid>        </item>
        <item>
            <title>How close is evidence to truth in evidence-based treatment of mental disorders?</title>
            <link>http://www.medworm.com/index.php?rid=5438787&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4j2w855pj278535%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Given the importance of the term ‘evidence’ in evidence-based medicine (EBM), the meaning of this term is evaluated, going
 back to the philosophical tradition and current meaning of the terms ‘evidence’ and ‘truth’. Based on this, current problems
 in the definition of evidence and in the grading of evidence in EBM are described, taking examples from the field of psychiatry
 and especially pharmacopsychiatry. These problems underline that the use of the term evidence in EBM is inconsistent and inconclusive.
 This should be fairly stated in all EBM-related publications, especially in EBM-based guidelines, to avoid severe misunderstandings
 in and outside the field of psychiatry. Although EBM might have increased empirically driven rational decision-making in...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5438787</comments>
            <pubDate>Mon, 21 Nov 2011 18:08:23 +0100</pubDate>
            <guid isPermaLink="false">5438787</guid>        </item>
        <item>
            <title>Correlation between psychological distress and C-reactive protein</title>
            <link>http://www.medworm.com/index.php?rid=5429248&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu2j20n71u46447v6%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00406-011-0276-5Authors
		Tomoyuki Kawada, Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8602 Japan
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5429248</comments>
            <pubDate>Tue, 15 Nov 2011 16:58:40 +0100</pubDate>
            <guid isPermaLink="false">5429248</guid>        </item>
        <item>
            <title>Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders</title>
            <link>http://www.medworm.com/index.php?rid=5419632&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffg2544715x7062u7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Current gold standard in the treatment of depression includes pharmacotherapeutic and psychotherapeutic strategies together
 with social support. Due to the actually discussed controversies concerning the differential efficacy of antidepressants,
 a contribution to a comprehensive clarification seems to be necessary to avert further deterioration and uncertainty from
 patients, relatives, and their treating psychiatrists and general practitioners. Both efficacy and clinical effectiveness
 of antidepressants in the treatment of depressive disorders can be confirmed. Clinically meaningful antidepressant treatment
 effects were confirmed in different types of studies. Methodological issues of randomized controlled studies, meta-analyses,
 and effectiveness studies will be ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5419632</comments>
            <pubDate>Mon, 14 Nov 2011 16:53:51 +0100</pubDate>
            <guid isPermaLink="false">5419632</guid>        </item>
        <item>
            <title>Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients</title>
            <link>http://www.medworm.com/index.php?rid=5405161&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2410412n4523k71%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this dual-isotope SPECT imaging study was to evaluate striatal dopamine transporter (DAT) and D2 receptor availability
 in first-episode never-treated and haloperidol-treated schizophrenic patients and whether the availability is associated with
 psychopathology. Twenty-four inpatients with a first acute schizophrenic episode were enrolled in the study; 12 of these patients
 were treated with haloperidol for 2&amp;nbsp;weeks before dual-isotope SPECT was performed, whereas the other 12 patients underwent
 the SPECT evaluation directly after enrollment. Twelve healthy control persons were also recruited and evaluated with the
 dual-isotope SPECT protocol. Psychopathology was assessed by the Positive and Negative Syndrome Scale and other scales. D2-radioligand
 bin...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5405161</comments>
            <pubDate>Sat, 12 Nov 2011 16:53:44 +0100</pubDate>
            <guid isPermaLink="false">5405161</guid>        </item>
        <item>
            <title>Exploring the structure of psychopathological symptoms: a re-analysis of AMDP data by robust nonmetric multidimensional scaling</title>
            <link>http://www.medworm.com/index.php?rid=5405162&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdmr21n61822535x4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This paper investigates the structure of psychopathological symptoms. Based on AMDP symptom profiles, a symptom space was
 calculated by robust nonmetric multidimensional scaling (NMDS) and the symptom structures of a sample dating from 1980 and
 a sample from 2002/2003 were compared. The method of NMDS presented in this study allows results from other studies to be
 confirmed and complemented. The symptom factors identified in the past by factor-analytic studies were replicated as clusters
 in two-dimensional symptom maps. Additionally, some theoretically assumed clusters of symptoms were detected that were not
 found in previous factor analysis approaches. From the results, which are depicted in a continuous space, new insights can
 be gained, especially with regard t...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5405162</comments>
            <pubDate>Mon, 07 Nov 2011 17:14:13 +0100</pubDate>
            <guid isPermaLink="false">5405162</guid>        </item>
        <item>
            <title>The neurological manifestations of trauma: lessons from World War I</title>
            <link>http://www.medworm.com/index.php?rid=5405163&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc737gn0019574320%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Changes in the clinical presentation of functional disorders and the influence of social and cultural factors can be investigated
 through the historical case notes from mental hospitals. World War I (WWI) was a potent trigger of functional disorders with
 neurological or psychiatric symptoms. We analysed 100 randomly selected case files of German servicemen admitted to the Department
 of Psychiatry of the Charité Medical School of Berlin University during WWI and classified them according to contemporaneous
 and retrospective modern diagnoses. We compared the clinical presentations with accounts in the German and British medical
 literature of the time. Most patients obtained the contemporaneous diagnosis of ‘psychopathic constitution’ or hysteria reflecting
 the ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5405163</comments>
            <pubDate>Mon, 07 Nov 2011 17:14:12 +0100</pubDate>
            <guid isPermaLink="false">5405163</guid>        </item>
        <item>
            <title>Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder</title>
            <link>http://www.medworm.com/index.php?rid=5398255&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F16863170rx303748%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The present study is aimed to exploring whether some single nucleotide polymorphisms (SNPs) within GRIA1, GRIA2 and GRIA4 could be associated with major depressive disorder (MDD) and whether they could predict clinical outcomes in Korean in-patients,
 respectively, treated with antidepressants. One hundred forty-five (145) patients with MDD and 170 healthy controls were genotyped
 for 17 SNPs within GRIA1, GRIA2 and GRIA4. Baseline and final clinical measures, including the Montgomery-Asberg Depression Rating Scale (MADRS) for patients with
 MDD, were recorded. No association was observed between alleles, genotypes and haplotypes under investigation and clinical
 and demographical variables. As a secondary finding, a marginal association was observed between rs4302506 a...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5398255</comments>
            <pubDate>Fri, 04 Nov 2011 16:49:59 +0100</pubDate>
            <guid isPermaLink="false">5398255</guid>        </item>
        <item>
            <title>Mood disorders in the light of genes, comorbidity and contemporary treatment</title>
            <link>http://www.medworm.com/index.php?rid=5378146&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl7471u1q22123085%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00406-011-0268-5Authors
		P. Falkai, Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, GermanyH.-J. Möller, Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Nussbaumstr. 7, 80336 Munich, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5378146</comments>
            <pubDate>Tue, 01 Nov 2011 16:50:32 +0100</pubDate>
            <guid isPermaLink="false">5378146</guid>        </item>
        <item>
            <title>General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry</title>
            <link>http://www.medworm.com/index.php?rid=5378147&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6k831j5567835487%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Current gold standard approaches to the treatment of depression include pharmacotherapeutic and psychotherapeutic interventions
 with social support. Due to current controversies concerning the efficacy of antidepressants in randomized controlled trials,
 the generalizability of study findings to wider clinical practice and the increasing importance of socioeconomic considerations,
 it seems timely to address the uncertainty of concerned patients and relatives, and their treating psychiatrists and general
 practitioners. We therefore discuss both the efficacy and clinical effectiveness of antidepressants in the treatment of depressive
 disorders. We explain and clarify useful measures for assessing clinically meaningful antidepressant treatment effects and
 the types of...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5378147</comments>
            <pubDate>Fri, 28 Oct 2011 06:06:00 +0100</pubDate>
            <guid isPermaLink="false">5378147</guid>        </item>
        <item>
            <title>Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects</title>
            <link>http://www.medworm.com/index.php?rid=5332732&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc46l0552qgu60133%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The connection between cholinergic transmission and cognitive performance has been established in behavioural studies. The
 specific contribution of the muscarinic receptor system on cognitive performance and brain activation, however, has not been
 evaluated satisfyingly. To investigate the specific contribution of the muscarinic transmission on neural correlates of working
 memory, we examined the effects of scopolamine, an antagonist of the muscarinic receptors, using functional magnetic resonance
 imaging (fMRI). Fifteen healthy male, non-smoking subjects performed a fMRI scanning session following the application of
 scopolamine (0.4&amp;nbsp;mg, i.v.) or saline in a placebo-controlled, repeated measure, pseudo-randomized, single-blind design. Working
 memory was probe...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5332732</comments>
            <pubDate>Mon, 17 Oct 2011 16:04:01 +0100</pubDate>
            <guid isPermaLink="false">5332732</guid>        </item>
        <item>
            <title>Depression is associated with low levels of 25-hydroxyvitamin D among Jordanian adults: results from a national population survey</title>
            <link>http://www.medworm.com/index.php?rid=5322303&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftr428118t425250n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although low serum 25-hydroxyvitamin D (25(OH)D) and elevated serum parathyroid hormone (PTH) have been associated with depression
 in clinical settings, this link in community-dwelling individuals is inconclusive. The present study aimed at examining the
 association between serum 25(OH)D and PTH levels and the presence of depression in a national population-based household sample
 of 4,002 Jordanian participants aged ≥25&amp;nbsp;years. The DASS21 depression scale was used to screen for depression, and serum concentrations
 of 25(OH)D and PTH were measured by radioimmunoassay. Multiple logistic regression models were used to explore the association
 between serum 25(OH)D and PTH levels and depression. The unadjusted odds ratio (OR) decreased linearly with increasing qua...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5322303</comments>
            <pubDate>Thu, 13 Oct 2011 05:47:34 +0100</pubDate>
            <guid isPermaLink="false">5322303</guid>        </item>
        <item>
            <title>Psychiatry interdisciplinary: the Berlin Congress of Psychiatry</title>
            <link>http://www.medworm.com/index.php?rid=5282789&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb2j0228074g809x3%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00406-011-0260-0Authors
		Frank Schneider, Klinik für Psychiatrie, Psychotherapie und Psychosomatik Universitätsklinikum Aachen, Pauwelsstr. 30, 52074 Aachen, GermanyMichael Grözinger, Klinik für Psychiatrie, Psychotherapie und Psychosomatik Universitätsklinikum Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5282789</comments>
            <pubDate>Sat, 01 Oct 2011 06:46:10 +0100</pubDate>
            <guid isPermaLink="false">5282789</guid>        </item>
        <item>
            <title>Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression</title>
            <link>http://www.medworm.com/index.php?rid=5282790&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F22tx64318735x456%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the efficacy evaluation of antidepressant treatments, the total score of the Hamilton Depression Rating Scale (HAMD) is
 still regarded as the ‘gold standard’. We previously had shown that the Inventory of Depressive Symptomatology (IDS) was more
 sensitive to detect depressive symptom changes than the HAMD17 (Helmreich et al. 2011). Furthermore, studies suggest that the unidimensional subscales of the HAMD, which capture the core depressive symptoms,
 outperform the full HAMD regarding the detection of antidepressant treatment effects. The aim of the present study was to
 compare several unidimensional subscales of the HAMD and the IDS regarding their sensitivity to changes in depression symptoms
 in a sample of patients with mild major, minor or subsyndromal de...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5282790</comments>
            <pubDate>Fri, 30 Sep 2011 05:53:26 +0100</pubDate>
            <guid isPermaLink="false">5282790</guid>        </item>
        <item>
            <title>Psychiatry under National Socialism: Remembrance and Responsibility</title>
            <link>http://www.medworm.com/index.php?rid=5282791&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh8l445683m657425%2F</link>
            <description>Content Type Journal ArticleCategory Commemorative speechPages 1-8DOI 10.1007/s00406-011-0243-1Authors
		Frank Schneider, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsklinikum Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5282791</comments>
            <pubDate>Fri, 30 Sep 2011 05:53:24 +0100</pubDate>
            <guid isPermaLink="false">5282791</guid>        </item>
        <item>
            <title>Neural correlates of the attention network test in schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=5282792&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg617141144802345%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Attentional deficits are prominent in schizophrenia, affecting nearly all cognitive functions. Human attention comprises three
 essential components: alerting, orienting and executive control. For the assessment of these functions, the attention network
 test (ANT) has been proposed and used in healthy controls and patients. In schizophrenia, the ANT has revealed behavioral
 deficits; however, the corresponding neural correlates have not been examined. In the present study, neural correlates of
 attention were investigated in 17 schizophrenia patients and 17 healthy controls using the ANT with fMRI. Behavioral deficits
 emerged in the alertness system with a reduced efficiency for temporal cues. In fMRI, changes were observed for all three
 domains–alerting, orienting...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5282792</comments>
            <pubDate>Fri, 30 Sep 2011 05:53:22 +0100</pubDate>
            <guid isPermaLink="false">5282792</guid>        </item>
        <item>
            <title>Narrated truths: the image of psychiatry in the media</title>
            <link>http://www.medworm.com/index.php?rid=5282793&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1q06w051r7u431v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In recent years, we have witnessed an increase in media attention on the subject of mental illness, which mass media frequently
 portray as a new phenomenon affecting large sections of the population. Reports about people suffering from mental disorders
 and on psychiatric or psychotherapeutic clinics, however, are often characterised by their emphasis on stereotypes and one-sided
 invariably negative attributes both in the choice of wording and the images used. This paper is an attempt to elucidate this
 apparent contradiction from both a narrative and a socio-historical perspective. In view of the development of modern moving
 image formats and storytelling techniques, it seeks to identify possible ways of harnessing the media to present a more considered
 and differe...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5282793</comments>
            <pubDate>Thu, 29 Sep 2011 06:19:15 +0100</pubDate>
            <guid isPermaLink="false">5282793</guid>        </item>
        <item>
            <title>Measuring the stigma of psychiatry and psychiatrists: development of a questionnaire</title>
            <link>http://www.medworm.com/index.php?rid=5270927&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fup8k402582761784%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The stigma of mental illness is a severe burden for people suffering from mental illness both in private and public life,
 also affecting their relatives, their close social network, and the mental health care system in terms of disciplines, providers,
 and institutions. Interventions against the stigma of mental illness employ complementary strategies (e.g., protest, education,
 and contact) and address different target groups (e.g., school children and teachers, journalists, stakeholders). Within this
 framework, the World Psychiatric Association has adopted an Action Plan with the goal to improve the image of psychiatry and
 to reduce potential stigmatizing attitudes toward psychiatry and psychiatrists. To evaluate such interventions, a questionnaire
 has been develo...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270927</comments>
            <pubDate>Tue, 27 Sep 2011 05:48:51 +0100</pubDate>
            <guid isPermaLink="false">5270927</guid>        </item>
        <item>
            <title>Methylation and the human brain: towards a new discipline of imaging epigenetics</title>
            <link>http://www.medworm.com/index.php?rid=5258231&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7j6187776729176w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The field of imaging genetics traditionally studies unidirectional associations between genes, brain functioning, and behavior.
 In a recent study by Ursini et al. (J Neurosci 31:6692–6698, 2011), imaging genetics methods are combined with epigenetic marks in living human beings. This approach may lead to a new field
 of imaging epigenetics, providing more mechanistic insight into causal pathways of how gene and environment interact and affect
 brain development.
 
 
	Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s00406-011-0261-zAuthors
		Corinde E. Wiers, Berlin School of Mind and Brain, Humboldt Universität zu Berlin, 10099 Berlin, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5258231</comments>
            <pubDate>Fri, 23 Sep 2011 16:19:25 +0100</pubDate>
            <guid isPermaLink="false">5258231</guid>        </item>
        <item>
            <title>Psychotherapy in psychiatry: the current situation and future directions in Germany</title>
            <link>http://www.medworm.com/index.php?rid=5258232&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Faj270065655r4125%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this article is to review how psychotherapy is dispensed to patients in psychiatric treatment and to render the
 future perspectives of psychotherapy in psychiatric outpatient and inpatient care in Germany. We demonstrate that—according
 to the currently available data about healthcare providers, allocation of financial resources and curricular regulations—the
 presently used definition of the term “psychotherapy” is ambiguous. One major problem for the application of psychotherapy
 in psychiatry is obviously constituted by the dominance of the major guideline therapies (“Richtlinienverfahren”) within psychiatric
 services. Here, guideline therapies do not meet the needs of a significant proportion of acutely, severely and/or chronically
 ill psyc...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5258232</comments>
            <pubDate>Wed, 21 Sep 2011 05:53:29 +0100</pubDate>
            <guid isPermaLink="false">5258232</guid>        </item>
        <item>
            <title>Exercise and physical activity in mental disorders</title>
            <link>http://www.medworm.com/index.php?rid=5258233&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn327tu2p353242l2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exercise (EX) and physical activity (PA) have been shown to prevent or delay the onset of several mental disorders and to
 have therapeutic effects in different groups of psychiatric disorders. This review focuses on studies investigating EX as
 therapeutic intervention in anxiety disorders, affective disorders, eating disorders, schizophrenia, and substance use disorders.
 Despite EX being discussed as a potential therapy for several decades, adequately powered randomized, controlled trials are
 sparse in most disorder groups. Nevertheless, evidence points toward disorder-specific benefits that can be induced by EX/PA.
 Mechanisms of the therapeutic effects of EX/PA are summarized, including metabolic and physiological as well as psychological
 aspects. Finally, implic...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5258233</comments>
            <pubDate>Tue, 20 Sep 2011 15:46:48 +0100</pubDate>
            <guid isPermaLink="false">5258233</guid>        </item>
        <item>
            <title>Impact of TCF4 on the genetics of schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=5258235&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq766l5313m281183%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations of the transcription factor 4 (TCF4) gene cause mental retardation with or without associated facial dysmorphisms
 and intermittent hyperventilation. Subsequently, a polymorphism of TCF4 was shown in a genome-wide association study to slightly
 increase the risk of schizophrenia. We have further analysed the impact of this TCF4 variant rs9960767 on early information
 processing and cognitive functions in schizophrenia patients. We have shown in a sample of 401 schizophrenia patients that
 TCF4 influences verbal memory in the Rey Auditory Verbal Learning Test. Contrary to expectations, carriers of the schizophrenia-associated
 allele showed better recognition, thus indicating that while TCF4 influences verbal memory, the TCF4-mediated schizophrenia
 risk is not...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5258235</comments>
            <pubDate>Tue, 20 Sep 2011 05:49:59 +0100</pubDate>
            <guid isPermaLink="false">5258235</guid>        </item>
        <item>
            <title>How much stress is needed to increase vulnerability to psychosis? A community assessment of psychic experiences (CAPE) evaluation 10 months after an earthquake in L’Aquila (Italy)</title>
            <link>http://www.medworm.com/index.php?rid=5258234&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq7w438jht8w57278%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Since severe stress can induce mental disorder symptoms that interact with vulnerability factors, the Community Assessment
 of Psychic Experiences (CAPE) was evaluated in a population of 419 young adults who survived an earthquake; results were compared
 to a database of 1,057 ‘non-exposed’ subjects. Unexpectedly, earthquake survivors showed lower CAPE scores for ‘small’ to
 ‘medium’ effect size. Post-trauma positive changes or re-appraisal for successful adaptation may explain these findings.
 
 
	Content Type Journal ArticleCategory Short CommunicationPages 1-4DOI 10.1007/s00406-011-0258-7Authors
		Alessandro Rossi, Institute of Experimental Medicine—Section of Psychiatry, University of L’Aquila, L’Aquila, ItalySilvia di Tommaso, Institute of Experim...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5258234</comments>
            <pubDate>Tue, 20 Sep 2011 05:49:59 +0100</pubDate>
            <guid isPermaLink="false">5258234</guid>        </item>
        <item>
            <title>From generation of biomarkers to treatment and psychosocial aspects of psychosis</title>
            <link>http://www.medworm.com/index.php?rid=5235348&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft3062421l283711t%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00406-011-0262-yAuthors
		P. Falkai, Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, GermanyH.-J. Möller, Psychiatry Hospital, Ludwigs-Maximililans-University Munich, Nussbaumstr. 7, 80336 Munich, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5235348</comments>
            <pubDate>Fri, 16 Sep 2011 16:43:23 +0100</pubDate>
            <guid isPermaLink="false">5235348</guid>        </item>
        <item>
            <title>World Health Organization 5-item well-being index: validation of the Brazilian Portuguese version</title>
            <link>http://www.medworm.com/index.php?rid=5220547&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq827j5q535402g02%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The psychological well-being dimension and depressive symptoms are both important variables in an individual’s health. In
 this study, we evaluated the World Health Organization 5-item well-being index (WHO-Five) internal and external validities,
 and accuracy in detecting depression. A total of 1,128 individuals between 18 and 65&amp;nbsp;years old from a rural Brazilian population
 were included. Cronbach’s alpha and factor analysis were performed for internal validation. Demographic variables means were
 compared, receiver operating characteristic (ROC) curve was constructed, and sensitivity, specificity and positive and negative
 predictive values for different cutoff points were calculated for external validation and accuracy in detecting depression.
 Cronbach’s ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5220547</comments>
            <pubDate>Mon, 12 Sep 2011 15:53:09 +0100</pubDate>
            <guid isPermaLink="false">5220547</guid>        </item>
        <item>
            <title>Italian psychiatric reform 1978: milestones for Italy and Europe in 2010?</title>
            <link>http://www.medworm.com/index.php?rid=5220549&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F55026536438w2w61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Italian psychiatric reform of 1978 was one of the most radical attempts in history to abolish the practise of custodial
 psychiatry using legislation. The work of the charismatic reformer Franco Basaglia had four main objectives, which have taken
 more than 30&amp;nbsp;years to achieve. Although the creation of outpatient mental health centres and a reduction in involuntary commitments
 occurred rapidly, the expensive development of small acute psychiatric departments in general hospitals as an alternative
 to psychiatric hospitals was implemented very slowly. According to a national survey by the Italian Ministry of Health, in
 2001, there were a total of 9,300 acute beds for all of Italy, of which as many as 4,000 were in private facilities. With
 1.72 acute beds per ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5220549</comments>
            <pubDate>Sat, 10 Sep 2011 05:47:49 +0100</pubDate>
            <guid isPermaLink="false">5220549</guid>        </item>
        <item>
            <title>Progressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patients</title>
            <link>http://www.medworm.com/index.php?rid=5220548&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe3167323p3270w68%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Schizophrenia is a neuropsychiatric disorder entailing progressive psychotic, cognitive and affective symptoms. Several imaging
 studies identified brain structure abnormalities in schizophrenia patients, particularly in fronto-temporal regions and evidence
 for progressive anatomical changes. Here, we synthesised these findings by quantitative coordinate-based meta-analysis, assessing
 regions of consistently reported brain structure changes, their physiological functions and the correlation of their likelihood
 with disease duration. The meta-analysis revealed four significant clusters of convergent grey matter reduction, while one
 cluster indicated higher grey matter values in patients. A voxel-wise analysis revealed a correlation between grey matter
 reduction and ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5220548</comments>
            <pubDate>Sat, 10 Sep 2011 05:47:49 +0100</pubDate>
            <guid isPermaLink="false">5220548</guid>        </item>
        <item>
            <title>Sport psychiatry and psychotherapy. Mental strains and disorders in professional sports. Challenge and answer to societal changes</title>
            <link>http://www.medworm.com/index.php?rid=5220550&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F21r0484w1431762u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Professional athletes are subject to massive somatic, social, and mental stress. Despite great public interest for athletic
 achievements, the emotional strains thereof are very poorly investigated and discussed. The main reason for this is the widespread
 assumption that only emotionally very strong athletes are able to compete at the highly professional level and therefore mental
 disorders do not exist in professional sports. But available research data about the prevalence of mental disorders in this
 area suggest that this hypothesis must be revised. With respect to depression and the overtraining syndrome, attempts have
 been made to demonstrate the difficulties with etiology, diagnostics, and treatment for sports psychiatry and psychotherapy.
 Scientifically, spo...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5220550</comments>
            <pubDate>Thu, 08 Sep 2011 05:54:19 +0100</pubDate>
            <guid isPermaLink="false">5220550</guid>        </item>
        <item>
            <title>Electroconvulsive therapy can benefit from controlled hyperventilation using a laryngeal mask</title>
            <link>http://www.medworm.com/index.php?rid=5220551&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhu453k606k982470%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypocapnia through hyperventilation is a well-known procedure in electroconvulsive therapy (ECT) to enhance seizure activity.
 However, it has mostly been applied in an uncontrolled manner. Originally intended for a better management of the supraglottic
 airway, laryngeal masks are more suited to monitor levels of CO2 during hyperventilation than face masks and thereby provide for the possibility of controlled hyperventilation (CHV). The
 impact of CHV was retrospectively studied in 114 consecutive patients; 65 of them had received ECT with CHV and 49 had received
 ECT with uncontrolled hyperventilation (UHV) directly prior to the time period when the laryneal mask was introduced to the
 ECT treatment procedure. The CO2 level in the CHV group was aimed at 30&amp;nbsp;mmHg o...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5220551</comments>
            <pubDate>Thu, 08 Sep 2011 05:54:18 +0100</pubDate>
            <guid isPermaLink="false">5220551</guid>        </item>
        <item>
            <title>A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis</title>
            <link>http://www.medworm.com/index.php?rid=5220552&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1n61921670857070%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations in postsynaptic scaffolding genes contribute to autism, thus suggesting a role in pathological processes in neurodevelopment.
 Recently, two de novo mutations in SHANK3 were described in schizophrenia patients. In most cases, abnormal SHANK3 genotype
 was also accompanied by cognitive disruptions. The present study queries whether common SHANK variants may also contribute
 to neuropsychological dysfunctions in schizophrenia. We genotyped five common coding or promoter variants located in SHANK1,
 SHANK2 and SHANK3. A comprehensive test battery was used to assess neuropsychological functions in 199 schizophrenia patients
 and 206 healthy control subjects. In addition, an independent sample of 77 subjects at risk for psychosis was analyzed for
 replication of si...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5220552</comments>
            <pubDate>Thu, 08 Sep 2011 05:54:16 +0100</pubDate>
            <guid isPermaLink="false">5220552</guid>        </item>
        <item>
            <title>Subtle deficits of cognitive theory of mind in unaffected first-degree relatives of schizophrenia patients</title>
            <link>http://www.medworm.com/index.php?rid=5205492&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2485174364m13358%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alterations of theory of mind (ToM) and empathy were implicated in the formation of psychotic experiences, and deficits in
 psychosocial functioning of schizophrenia patients. Inspired by concepts of neurocognitive endophenotypes, the existence of
 a distinct, potentially neurobiologically based social-cognitive vulnerability marker for schizophrenia is a matter of ongoing
 debate. The fact that previous research on social-cognitive deficits in individuals at risk yielded contradictory results
 may partly be due to an insufficient differentiation between qualitative aspects of ToM. Thirty-four unaffected first-degree
 relatives of schizophrenia patients (21 parents, 8 siblings, 5 children; f/m: 30/4; mean age: 48.1&amp;nbsp;±&amp;nbsp;12.7&amp;nbsp;years) and 34 controls
 subjects...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5205492</comments>
            <pubDate>Sun, 04 Sep 2011 10:46:51 +0100</pubDate>
            <guid isPermaLink="false">5205492</guid>        </item>
        <item>
            <title>The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms</title>
            <link>http://www.medworm.com/index.php?rid=5205491&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2wpt08m6791t0717%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Genetic factors determining the response to antipsychotic treatment in schizophrenia are poorly understood. A new schizophrenia
 susceptibility gene, the zinc-finger gene ZNF804A, has recently been identified. To assess the pharmacogenetic importance
 of this gene, we treated 144 schizophrenia patients and assessed the response of positive and negative symptoms by PANSS.
 Patients homozygous for the ZNF804A risk allele for schizophrenia (rs1344706 AA) showed poorer improvement of positive symptoms
 (7.35&amp;nbsp;±&amp;nbsp;0.46) compared to patients with a protective allele (9.41&amp;nbsp;±&amp;nbsp;0.71, P&amp;nbsp;=&amp;nbsp;0.022). This provides further evidence that ZNF804A is of functional relevance to schizophrenia and indicates that ZNF804A
 may be a novel target for pharmacological ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5205491</comments>
            <pubDate>Sun, 04 Sep 2011 10:46:51 +0100</pubDate>
            <guid isPermaLink="false">5205491</guid>        </item>
        <item>
            <title>White matter abnormalities and their impact on attentional performance in adult attention-deficit/hyperactivity disorder</title>
            <link>http://www.medworm.com/index.php?rid=5191945&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu8m7x57h846t2760%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Inattention is the most important behavioral feature of adult patients with attention-deficit/hyperactivity disorder (ADHD).
 Neuroimaging studies in ADHD have demonstrated abnormalities primarily in the frontostriatal circuitry and were mostly conducted
 in children. We investigated white matter (WM) integrity in adult ADHD patients and the correlation of WM microstructure and
 neuropsychological parameters in 37 (21 men) never-medicated adult ADHD patients and 34 age- and gender-matched healthy controls.
 All subjects underwent clinical interviews, rating scales, and neuropsychological tests of attentional performance. Diffusion
 tensor imaging (DTI) was acquired, and 12 WM regions-of-interest (ROIs) within the attentional network were chosen. Group
 differences of me...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5191945</comments>
            <pubDate>Wed, 31 Aug 2011 05:52:33 +0100</pubDate>
            <guid isPermaLink="false">5191945</guid>        </item>
        <item>
            <title>The reputation of psychiatry in the first half of the twentieth century</title>
            <link>http://www.medworm.com/index.php?rid=5174442&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg37vt973k6m28209%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The article evaluates the arguments used by German psychiatrists in the first half of the twentieth century to raise their
 professional reputation. The arguments, which were used in Wilhelmine Germany and in the 1920s, changed with the establishment
 of the NS-regime. While psychiatrists claimed for open care systems and for more transparency of psychiatric practice to the
 public in the first decades of the twentieth century, psychiatry became a crucial part of NS-health policies after 1933. The
 psychiatrist’s participation in the largest systematic action to kill mentally ill patients known in history forced them to
 search for ways to legitimatize the murder program and to integrate it into a therapeutical view of future psychiatry by trying
 to avoid arbitrarine...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5174442</comments>
            <pubDate>Fri, 26 Aug 2011 05:48:41 +0100</pubDate>
            <guid isPermaLink="false">5174442</guid>        </item>
        <item>
            <title>Apology, responsibility, memory. Coming to terms with Nazi medical crimes: the example of the Max Planck Society</title>
            <link>http://www.medworm.com/index.php?rid=5174443&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0k44363m25l2104%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In June 2001, the then president of the Max Planck Society addressed a formal apology to survivors of Nazi medical crimes.
 Starting from this ritual of repentance, the paper examines the participants’ diverse views of how to deal with the medical
 crimes of National Socialism. In comparison with the DGPPN, it asks about possibilities of going beyond historical retrospection
 to fulfil the imperative of remembrance.
 
 
	Content Type Journal ArticleCategory ReviewPages 1-5DOI 10.1007/s00406-011-0241-3Authors
		Carola Sachse, Institut für Zeitgeschichte, Universität Wien, Spitalgasse 2-4, Hof 1, 1090 Wien, Austria
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5174443</comments>
            <pubDate>Thu, 25 Aug 2011 15:51:13 +0100</pubDate>
            <guid isPermaLink="false">5174443</guid>        </item>
        <item>
            <title>Schizophrenia as a disorder of disconnectivity</title>
            <link>http://www.medworm.com/index.php?rid=5169364&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F26031148w885574t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Schizophrenia is considered as a neurodevelopmental disorder with genetic and environmental factors playing a role. Animal
 models show that developmental hippocampal lesions are causing disconnectivity of the prefrontal cortex. Magnetic resonance
 imaging and postmortem investigations revealed deficits in the temporoprefrontal neuronal circuit. Decreased oligodendrocyte
 numbers and expression of oligodendrocyte genes and synaptic proteins may contribute to disturbances of micro- and macro-circuitry
 in the pathophysiology of the disease. Functional connectivity between cortical areas can be investigated with high temporal
 resolution using transcranial magnetic stimulation (TMS), electroencephalography (EEG), and magnetoencephalography (MEG).
 In this review, disconne...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169364</comments>
            <pubDate>Wed, 24 Aug 2011 16:02:08 +0100</pubDate>
            <guid isPermaLink="false">5169364</guid>        </item>
        <item>
            <title>Aetiology of anorexia nervosa: from a “psychosomatic family model” to a neuropsychiatric disorder?</title>
            <link>http://www.medworm.com/index.php?rid=5169365&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F157035l0p3143053%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Eating disorders and, in particular, anorexia nervosa (AN) have morbidity and mortality rates that are among the highest of
 any mental disorders and are associated with significant functional impairment. More than 25&amp;nbsp;years ago, several researchers
 hypothesised that the prerequisite for the development of AN was a family process characterised by an overprotective and conflict-avoiding
 parent–child interaction. Family studies, however, suggest that AN is a complex genetic disorder that is likely expressed
 primarily by temperament and specific traits during childhood, including inhibition, perfectionism and harm avoidance. Recent
 studies have described an impaired flexibility and deficits in social cognition that are independent of body weight and the
 current ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169365</comments>
            <pubDate>Wed, 24 Aug 2011 16:02:06 +0100</pubDate>
            <guid isPermaLink="false">5169365</guid>        </item>
        <item>
            <title>Treating the untreated: applying a community-based, culturally sensitive psychiatric intervention to confined and physically restrained mentally ill individuals in Bali, Indonesia</title>
            <link>http://www.medworm.com/index.php?rid=5169366&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frm743646657475q6%2F</link>
            <description>This study identified, mapped and treated the clinical features of mentally ill people, who had been isolated and restrained
 by family and community members as a result of a functional failure of the traditional medical, hospital-based mental health
 model currently practiced in Indonesia. A 10-month epidemiological population survey was carried out in Karangasem regency
 of Bali, Indonesia. A total of 404,591 individuals were clinically interviewed, of which 895 individuals with mental health
 problems were identified, with 23 satisfying criteria of physical restraint and confinement. Of the latter, twenty were males;
 age range was 19–69&amp;nbsp;years, all diagnosed by the researchers with schizophrenia-spectrum disorder (ICD-10 diagnostic criteria).
 Duration of restraint ranged from 3&amp;...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169366</comments>
            <pubDate>Wed, 24 Aug 2011 07:18:48 +0100</pubDate>
            <guid isPermaLink="false">5169366</guid>        </item>
        <item>
            <title>“Resources for each other.” The society of German neurologists and psychiatrists and the Nazi “health leadership”</title>
            <link>http://www.medworm.com/index.php?rid=5169367&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq546r5qw404x1443%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The history of the German Association for Psychiatry and—after its merger with the Society of German Neurologists in 1935—the
 Society of German Neurologists and Psychiatrists (Gesellschaft deutscher Neurologen und Psychiater, GDNP) during the period
 of National Socialism has been subjected to only rudimentary research. The conventionally accepted idea that two independent
 professional associations were “coordinated” from above and turned into the extended arm of Nazi genetic health policy (Erbgesundheitspolitik) against their will must be reconsidered. This paper asks how the relationship between the GDNP and the Nazi state can be
 described adequately. Psychiatry and neurology as practice and science, and the biopolicy development dictatorship of National
 S...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169367</comments>
            <pubDate>Wed, 24 Aug 2011 07:18:47 +0100</pubDate>
            <guid isPermaLink="false">5169367</guid>        </item>
        <item>
            <title>Deficits in social cognition: a marker for psychiatric disorders?</title>
            <link>http://www.medworm.com/index.php?rid=5169368&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F04n077812m0v7p57%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Research on social cognition focuses on several human abilities with a huge diversity in the approaches to tap the different
 functions. Empathy, for instance, is a rather elaborated human ability, and several recent studies point to significant impairments
 in patients suffering from psychiatric disorders, such as schizophrenia or autism. Neuroimaging data from these patients commonly
 indicate neural dysfunctions accompanying the behavioral deficits. Studying the neural correlates of social cognition is of
 particular importance, because deficits in these domains may explain the major dysfunctions in psychiatric disorders that
 prevent effective (re) integration into work and social life. It has also become clearer that social cognition deficits, similar
 to emotion d...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169368</comments>
            <pubDate>Wed, 24 Aug 2011 07:18:45 +0100</pubDate>
            <guid isPermaLink="false">5169368</guid>        </item>
        <item>
            <title>Correlation with statistical significance and its explanation rate: comment on Minelli et al., “BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects.” (Eur Arch Psychiatry Clin Neurosci doi:10.1007/s00406-011-0189-3)</title>
            <link>http://www.medworm.com/index.php?rid=5125558&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv504520802l11m24%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-011-0236-0Authors
		Tomoyuki Kawada, Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8602 Japan
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5125558</comments>
            <pubDate>Wed, 10 Aug 2011 15:46:40 +0100</pubDate>
            <guid isPermaLink="false">5125558</guid>        </item>
        <item>
            <title>Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes</title>
            <link>http://www.medworm.com/index.php?rid=5107156&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj5156172n26007rk%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To assess the clinical validity of individual DSM-IV criteria for hypomania. In an international sample of 5,635 patients
 with major depressive episodes (Bridge Study), DSM-IV criteria for hypomania (stem questions, number and quality of symptoms,
 duration and exclusion criteria) were systematically assessed and their validity analysed on the basis of clinical data including
 family history, course, and other clinical characteristics. Three stem questions for hypomania, irritability, elevated mood
 and the added question of increased activity, showed comparable validity. The results support the current DSM-IV requirement
 for a higher symptom threshold (4 of 7 hypomanic symptoms) in cases of irritable mood. Longer durations of hypomanic episodes
 were associated with ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5107156</comments>
            <pubDate>Fri, 05 Aug 2011 05:59:37 +0100</pubDate>
            <guid isPermaLink="false">5107156</guid>        </item>
        <item>
            <title>Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study</title>
            <link>http://www.medworm.com/index.php?rid=5107155&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft742745464u17287%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diffusion tensor imaging (DTI) demonstrates decline of fractional anisotropy (FA) as a marker of fiber tract integrity in
 Alzheimer’s disease (AD). We aimed to assess the longitudinal course of white matter microstructural changes in AD and healthy
 elderly control (HC) subjects and to evaluate the effects of treatment with the cholinesterase inhibitor galantamine on white
 matter microstructure in AD patients. We enrolled 28 AD patients and 11 healthy elderly control subjects (HC). AD patients
 were randomly assigned to 6-month double-blind galantamine treatment or placebo, with a 6-month open-label extension phase.
 DTI was performed at baseline, as well as at 6 and 12-month follow-up in AD patients. The HC subjects underwent DTI at baseline
 and 12-month follow-up...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5107155</comments>
            <pubDate>Fri, 05 Aug 2011 05:59:37 +0100</pubDate>
            <guid isPermaLink="false">5107155</guid>        </item>
        <item>
            <title>Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)</title>
            <link>http://www.medworm.com/index.php?rid=5103216&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl00581336g754m73%2F</link>
            <description>This study also included a small descriptive arm in which patients
 could also be randomized to aripiprazole. Results of this exploratory analysis are described here. Clinically stable adults
 with schizophrenia or schizoaffective disorder previously treated with oral risperidone, olanzapine, or an oral conventional
 antipsychotic were randomized to RLAI or aripiprazole. Efficacy and tolerability were monitored for up to 24&amp;nbsp;months. A total
 of 45 patients were treated with aripiprazole (10–30&amp;nbsp;mg/day) and 329 patients with RLAI (25–50&amp;nbsp;mg i.m. every 2&amp;nbsp;weeks). Relapse
 occurred in 27.3% (95% CI: 15.0–42.8%) of aripiprazole-treated and 16.5% (95% CI: 12.7–21.0%) of RLAI-treated patients. Kaplan–Meier
 estimates of mean (standard error) relapse-free period were 313...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5103216</comments>
            <pubDate>Tue, 02 Aug 2011 05:52:36 +0100</pubDate>
            <guid isPermaLink="false">5103216</guid>        </item>
        <item>
            <title>General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=5077352&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe651372426365670%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Earlier studies suggested more severe overall cognitive impairments in deficit versus non-deficit schizophrenia; however,
 the specific contribution of different cognitive domains to this overall cognitive impairment remains unclear. The purpose
 of this study was to compare the two subtypes in general cognitive functioning as well as in individual cognitive domains
 using the composite score approach. One hundred and forty-three patients fulfilling the criteria for the deficit syndrome
 were compared with 123 patients diagnosed with non-deficit schizophrenia. Neurocognitive functioning was assessed by a neuropsychological
 test battery measuring the domains of sustained vigilance/attention, working memory, short-term memory, verbal memory, cognitive
 flexibility, and i...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5077352</comments>
            <pubDate>Tue, 26 Jul 2011 15:48:23 +0100</pubDate>
            <guid isPermaLink="false">5077352</guid>        </item>
        <item>
            <title>Subjective emotional over-arousal to neutral social scenes in paranoid schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=5077353&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61223lq7317v5320%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;From the clinical practice and some experimental studies, it is apparent that paranoid schizophrenia patients tend to assign
 emotional salience to neutral social stimuli. This aberrant cognitive bias has been conceptualized to result from increased
 emotional arousal, but direct empirical data are scarce. The aim of the present study was to quantify the subjective emotional
 arousal (SEA) evoked by emotionally non-salient (neutral) compared to emotionally salient (negative) social stimuli in schizophrenia
 patients and healthy controls. Thirty male inpatients with paranoid schizophrenia psychosis and 30 demographically matched
 healthy controls rated their level of SEA in response to neutral and negative social scenes from the International Affective
 Picture System an...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5077353</comments>
            <pubDate>Tue, 26 Jul 2011 15:48:22 +0100</pubDate>
            <guid isPermaLink="false">5077353</guid>        </item>
        <item>
            <title>Critical trial-related criteria in acute schizophrenia studies</title>
            <link>http://www.medworm.com/index.php?rid=5077354&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3p4910364541tu48%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Trial Criteria in Schizophrenia Working Group was convened in November 2007 to define consensus criteria for clinical
 trials in patients suffering from acute schizophrenia with special focus on placebo-controlled trials and withdrawal conditions.
 Clinical trials involving patients give rise to ethical and medico-legal dilemmas. Essential research of new drugs may potentially
 expose patients to ineffective treatment regimens or placebo. The complexity of the problem increases when dealing with mentally
 ill patients. The Working Group’s criteria are thought to cover different aspects important in conducting clinical trials
 namely to ensure the patient’s safety, to present criteria that would allow the ethics committees to agree to the proposed
 criteria and t...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5077354</comments>
            <pubDate>Tue, 26 Jul 2011 05:48:27 +0100</pubDate>
            <guid isPermaLink="false">5077354</guid>        </item>
        <item>
            <title>Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI</title>
            <link>http://www.medworm.com/index.php?rid=5061899&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp6146l0x50518250%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alzheimer’s disease (AD) and mild cognitive impairment (MCI), the transitional clinical stage between cognition in normal
 aging and dementia, have been linked to abnormalities in brain perfusion. Pulsed arterial spin labeling (PASL) is a magnetic
 resonance imaging (MRI) technique for evaluating brain perfusion. The present study aimed to determine regional perfusion
 abnormalities in 19 patients with mild dementia in AD and 24 patients with MCI as compared to 24 cognitively healthy elderly
 controls using PASL. In line with nuclear imaging methods, lower perfusion in patients with MCI and AD was found mainly in
 the parietal lobe, but also in angular and middle temporal areas as well as in the left middle occipital lobe and precuneus.
 Our data imply that PASL may b...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5061899</comments>
            <pubDate>Sat, 23 Jul 2011 05:54:09 +0100</pubDate>
            <guid isPermaLink="false">5061899</guid>        </item>
        <item>
            <title>Psychobiological responses to unpleasant emotions in cannabis users</title>
            <link>http://www.medworm.com/index.php?rid=5061900&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9x51tw33611m3g2l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Aim of this paper is to investigate the psychobiological reactions to experimentally induced negative emotional states in
 active marijuana-dependent smokers and whether changes in emotional reactivity were reversed by prolonged abstinence. Twenty-eight
 patients were randomly included into group A (fourteen active marijuana-dependent smokers) or group B (fourteen abstinent
 marijuana-dependent subjects). Emotional response evaluation of group B subjects was assessed after 6&amp;nbsp;months of abstinence.
 Fourteen healthy volunteers, matched for age and sex, were used as controls. Psychometric and emotional response evaluations
 were performed by administering Symptoms Check List-90 and State-Trait Anxiety Inventory Y-1 (STAI). Neutral and unpleasant
 set of pictures selec...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5061900</comments>
            <pubDate>Tue, 19 Jul 2011 23:23:34 +0100</pubDate>
            <guid isPermaLink="false">5061900</guid>        </item>
        <item>
            <title>Investigation of schizophrenic patients from Istanbul, Turkey for the presence of West Nile virus</title>
            <link>http://www.medworm.com/index.php?rid=4997384&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft6267066341u0721%2F</link>
            <description>In conclusion,
 the results of this study show that antibodies to WNV in people do not seem to be associated with schizophrenia. However,
 detecting antibodies to WNV in schizophrenic patients suggests that WNV infection should be considered in endemic areas as
 it may play role in psychiatric diseases.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00406-011-0222-6Authors
		M. Aslan, Cerrahpasa Faculty of Medicine, Microbiology and Clinical Microbiology Department, The University of Istanbul, Istanbul, TurkeyB. Kocazeybek, Cerrahpasa Faculty of Medicine, Microbiology and Clinical Microbiology Department, The University of Istanbul, Istanbul, TurkeyN. Turan, Veterinary Faculty, Department of Virology, The University of Istanbul, Avcilar, Istanbul, TurkeyA. R. Karakose, Cerrahpasa F...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4997384</comments>
            <pubDate>Sat, 02 Jul 2011 05:43:53 +0100</pubDate>
            <guid isPermaLink="false">4997384</guid>        </item>
        <item>
            <title>Pain, affect and psychotic illness</title>
            <link>http://www.medworm.com/index.php?rid=4920838&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe915563301r81q15%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-011-0221-7Authors
		H.-J. Möller, Psychiatry Hospital, Ludwigs-Maximilians-University Munich, Nussbaumstr. 7, 80336 Munich, GermanyP. Falkai, Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4920838</comments>
            <pubDate>Wed, 08 Jun 2011 15:46:59 +0100</pubDate>
            <guid isPermaLink="false">4920838</guid>        </item>
        <item>
            <title>Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders</title>
            <link>http://www.medworm.com/index.php?rid=4901992&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F323444595706v876%2F</link>
            <description>The objective of this study was
 to examine the concordance and clinical validity of alternative definitions of SP in patients with nonaffective psychotic
 disorders. Two-hundred drug-naive patients with nonaffective psychotic disorders were examined for core parkinsonian signs,
 including bradykinesia, rigidity, and tremor, and diagnosed of SP according to the Simpson-Angus Scale (SAS) cutoff criterion,
 the UK Parkinson’s disease brain bank (UKPDBB) criteria, the National Institute of Neurological Disorders and Stroke (NINDS)
 criteria, and criteria requiring the presence of all three core features (full syndrome criteria). Parkinsonian signs and
 criteria were examined in relation to a number of relevant clinical variables. The most frequent sign was rigidity (33.5%)
 followed by brad...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4901992</comments>
            <pubDate>Mon, 30 May 2011 17:08:57 +0100</pubDate>
            <guid isPermaLink="false">4901992</guid>        </item>
        <item>
            <title>Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder</title>
            <link>http://www.medworm.com/index.php?rid=4901993&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft585074644113l56%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aims of this study were to analyze the presence of gender differences in the phenotypic expression of schizophrenia at
 the onset of illness and to explore whether these differences determine clinical and functional outcome 2&amp;nbsp;years after the
 initiation of treatment. Data from 231 first-episode-psychosis non-substance-dependent patients (156 men and 75 women) participating
 in a large-scale naturalistic open-label trial with risperidone were recorded at inclusion and months 1, 6, 12, and 24. Men
 presented a significant earlier age of onset (24.89&amp;nbsp;years vs. 29.01&amp;nbsp;years in women), poorer premorbid functioning, and a higher
 presence of prodromal and baseline negative symptoms. Women were more frequently married or lived with their partner and children
...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4901993</comments>
            <pubDate>Thu, 26 May 2011 05:48:28 +0100</pubDate>
            <guid isPermaLink="false">4901993</guid>        </item>
        <item>
            <title>Repetitive magnetic stimulation of human-derived neuron-like cells activates cAMP-CREB pathway</title>
            <link>http://www.medworm.com/index.php?rid=4840940&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fng21540622r1wr6x%2F</link>
            <description>In conclusion, we introduce here
 a novel in vitro system responding to rTMS at the level of second messenger signaling. The use of human-derived cells with
 neuron-like properties will prove useful for further studies on the cellular effects of rTMS.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00406-011-0217-3Authors
		Julian Hellmann, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charité Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, GermanyRene Jüttner, Developmental Neurobiology, Max-Delbrück-Center, Robert-Rössle-Str. 10, 13092 Berlin, GermanyClarisse Roth, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charité Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, GermanyMalek Bajbouj, Klinik und Hochschulambulanz für Ps...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4840940</comments>
            <pubDate>Thu, 12 May 2011 18:53:08 +0100</pubDate>
            <guid isPermaLink="false">4840940</guid>        </item>
        <item>
            <title>Differential expression of HINT1 in schizophrenia brain tissue</title>
            <link>http://www.medworm.com/index.php?rid=4812847&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff05r22752715087q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent findings in the literature suggest a relation between histidine triad nucleotide-binding protein-1 (HINT1) and psychiatric
 disorders such as major depression, anxiety, and schizophrenia, although its physiological roles are not completely comprehended.
 Using Western blot, we compared HINT1 protein expression in the postmortem dorsolateral prefrontal cortex and thalamus of
 schizophrenia patients and healthy controls for contributing to elucidate the role of HINT1 in schizophrenia pathophysiology.
 HINT1 was found to be downregulated in the dorsolateral prefrontal cortex and upregulated in the thalamus. Our results combined
 to previous studies in human samples and preclinical models support the notion that HINT1 must be more explored as a potential
 target for ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4812847</comments>
            <pubDate>Sat, 07 May 2011 15:45:34 +0100</pubDate>
            <guid isPermaLink="false">4812847</guid>        </item>
        <item>
            <title>Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics</title>
            <link>http://www.medworm.com/index.php?rid=4788833&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw456h44646637057%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the present study is to identify the relative contribution of patient and caregiver characteristics in a sample
 of primary carers of patients with chronic mental disorders living in the community. As carers were recruited from caregiver
 organizations, mainly mothers of an adult child suffering from schizophrenia participated in the study (n&amp;nbsp;=&amp;nbsp;102). Within a comprehensive transactional stress model, burden was assessed with respect to objective and subjective burden,
 cognitive-emotional well-being, psychological distress and subjective quality of life. Primary stressors include illness-related
 characteristics of the patient, and a number of personal dispositions and resources of the caregivers were included as potential
 moderating variables. Mul...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4788833</comments>
            <pubDate>Tue, 03 May 2011 05:52:17 +0100</pubDate>
            <guid isPermaLink="false">4788833</guid>        </item>
        <item>
            <title>Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder</title>
            <link>http://www.medworm.com/index.php?rid=4753452&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq57157452q422542%2F</link>
            <description>This study investigated the effect of
 familial risk of SZ or BD on these two aspects of inhibitory control. Seventeen healthy first-degree relatives of patients
 with BD (BD-R), 15 healthy relatives of patients with SZ (SZ-R) and 23 demographically matched controls were compared in terms
 of their performance during Controlled Oral Word Association (COWA), which measures contextually driven response selection,
 and during the Hayling Sentence Completion Test (HSCT), which assesses contextual response selection and inhibition. Compared
 to controls and BD-R, SZ-R showed deficits in contextual information processing that resulted in spontaneous errors in the
 COWA as well as deficits in response inhibition during the HSCT that resulted in higher error rates. BD-R also showed deficits
 in re...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4753452</comments>
            <pubDate>Fri, 22 Apr 2011 05:45:18 +0100</pubDate>
            <guid isPermaLink="false">4753452</guid>        </item>
        <item>
            <title>Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system</title>
            <link>http://www.medworm.com/index.php?rid=4753453&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6681465250n5544%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The brain-derived neurotrophic factor (BDNF) is a key regulator of synaptic plasticity and has been suggested to be involved
 in the pathophysiology and pathogenesis of psychotic disorders, with particular emphasis on dysfunctions of the hippocampus.
 The aim of the present study was to replicate and to extend prior findings of BDNF val66met genotype effects on hippocampal
 volume and N-acetyl aspartate (NAA) levels. Hundred and fifty-eight caucasians (66 schizophrenic, 45 bipolar, and 47 healthy
 subjects; 105 subjects underwent MRI and 103 MRS scanning) participated in the study and were genotyped with regard to the
 val66met polymorphism (rs6265) of the BDNF gene. Hippocampal volumes were determined using structural magnetic resonance imaging
 (MRI), and measures of ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4753453</comments>
            <pubDate>Thu, 21 Apr 2011 06:14:01 +0100</pubDate>
            <guid isPermaLink="false">4753453</guid>        </item>
        <item>
            <title>Internet suicide searches and the incidence of suicide in young people in Japan</title>
            <link>http://www.medworm.com/index.php?rid=4744743&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmu786428u229123g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although several case reports have suggested a relationship between accessing Internet suicide sites and the incidence of
 suicide, the influence of the Internet on the incidence of suicide is not known. Thus, we examined the association between
 Internet suicide-related searches and the incidence of suicide in 20- and 30-year-old individuals in Japan. The Box–Jenkins
 transfer function model was applied to monthly time series data from January 2004 to May 2010 (77&amp;nbsp;months). The terms “hydrogen
 sulfide,” “hydrogen sulfide suicide,” and “suicide hydrogen sulfide suicide” at (t-11) were related to the incidence of suicide among people aged in their 20&amp;nbsp;s (P&amp;nbsp;=&amp;nbsp;0.005, 0.005, and 0.006, respectively) and people aged in their 30&amp;nbsp;s (P&amp;nbsp...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4744743</comments>
            <pubDate>Wed, 20 Apr 2011 06:04:00 +0100</pubDate>
            <guid isPermaLink="false">4744743</guid>        </item>
        <item>
            <title>The estimated prevalence and correlates of adult ADHD in a German community sample</title>
            <link>http://www.medworm.com/index.php?rid=4744744&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8v303p4663178r73%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Little research on the prevalence and correlates of adult ADHD has been conducted outside the United States. The aim of the
 present study was to estimate the prevalence and correlates of adult ADHD in a large representative sample of the German population
 aged 18–64&amp;nbsp;years (n&amp;nbsp;=&amp;nbsp;1,655). Two self-rating screening instruments to assess childhood and adult ADHD symptomatology were used to estimate the
 prevalence of ADHD. A 4-item screening tool was used to assess probable cases of current depression and anxiety (Patient Health
 Questionnaire). The estimated crude prevalence rate of current ADHD was 4.7%. Adult ADHD was significantly associated with
 lower age, low educational level, unemployment, marital status (never married and divorced), and rural resi...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4744744</comments>
            <pubDate>Sun, 17 Apr 2011 05:49:21 +0100</pubDate>
            <guid isPermaLink="false">4744744</guid>        </item>
        <item>
            <title>Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=4642292&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8p7145m762344t61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ventricular enlargement is one of the most consistent abnormal structural brain findings in schizophrenia and has been used
 to infer brain shrinkage. However, whether ventricular enlargement is related to local overlying cortex and/or adjacent subcortical
 structures or whether it is related to brain volume change globally has not been assessed. We systematically assessed interrelations
 of ventricular volumes with gray and white matter volumes of 40 Brodmann areas (BAs), the thalamus and its medial dorsal nucleus
 and pulvinar, the internal capsule, caudate and putamen. We acquired structural MRI ( patients with schizophrenia (n&amp;nbsp;=&amp;nbsp;64) and healthy controls (n&amp;nbsp;=&amp;nbsp;56)) and diffusion tensor fractional anisotropy (FA) (untreated schizophrenia n&amp;nbsp;=&amp;nb...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4642292</comments>
            <pubDate>Wed, 23 Mar 2011 16:57:59 +0100</pubDate>
            <guid isPermaLink="false">4642292</guid>        </item>
        <item>
            <title>EEG alterations during treatment with olanzapine</title>
            <link>http://www.medworm.com/index.php?rid=4636252&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm6236886j5435806%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this naturalistic observational study was to investigate EEG alterations in patients under olanzapine treatment
 with a special regard to olanzapine dose and plasma concentration. Twenty-two in-patients of a psychiatric university ward
 with the monodiagnosis of paranoid schizophrenia (ICD-10: F20.0), who received a monotherapy of olanzapine were included in
 this study. All patients had a normal alpha-EEG before drug therapy, and did not suffer from brain-organic dysfunctions, as
 verified by clinical examination and cMRI scans. EEG and olanzapine plasma levels were determined under steady-state conditions
 (between 18 and 22&amp;nbsp;days after begin of treatment). In 9 patients (40.9%), pathological EEG changes (one with spike-waves)
 consecutive to olanzapine...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4636252</comments>
            <pubDate>Wed, 23 Mar 2011 06:07:59 +0100</pubDate>
            <guid isPermaLink="false">4636252</guid>        </item>
        <item>
            <title>Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., “intervention in at-risk states for developing psychosis.” (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90–94)</title>
            <link>http://www.medworm.com/index.php?rid=4636253&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F55419n7471t0u676%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-011-0210-xAuthors
		Hsiang-Yuan Lin, Department of Psychiatry, National Taiwan University Hospital, No. 7 Chung Shan S. Rd, Taipei, 10002 TaiwanYen-Nan Chiu, Department of Psychiatry, National Taiwan University Hospital, No. 7 Chung Shan S. Rd, Taipei, 10002 TaiwanChen-Chung Liu, Department of Psychiatry, National Taiwan University Hospital, No. 7 Chung Shan S. Rd, Taipei, 10002 Taiwan
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4636253</comments>
            <pubDate>Wed, 23 Mar 2011 06:07:58 +0100</pubDate>
            <guid isPermaLink="false">4636253</guid>        </item>
        <item>
            <title>Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression</title>
            <link>http://www.medworm.com/index.php?rid=4621992&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb78670307pr0x2p5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In recent studies, the glutamate (Glu) level has been quantified using the modified STEAM sequence on 3T MRI. We enrolled
 15 healthy volunteers and a group of 51 patients who experienced stroke for the first time and had a good prognosis. The patients
 with infarction were divided into three groups according to their scores by using the DSM-IV diagnostic criteria for major
 depressive disorder and the 17-item Hamilton Depression Rating Scale (HDRS). We studied the association between post-stroke
 depression and 1H-MRS measurements in unaffected frontal lobes. Single-voxel proton magnetic resonance spectroscopy (1H-MRS) was performed to assess N-acetylaspartate/creatine (NAA)/Cr, (Glu)/Cr, choline (Cho)/Cr, and myoinositol (mI)/Cr ratios in stroke patients. The 11
 pati...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4621992</comments>
            <pubDate>Sat, 19 Mar 2011 02:54:08 +0100</pubDate>
            <guid isPermaLink="false">4621992</guid>        </item>
        <item>
            <title>Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies</title>
            <link>http://www.medworm.com/index.php?rid=4610640&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg3804756458h7xl2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As a relatively large body of research has been published up to now, it may be informative to explore whether the use of endophenotypes
 has produced consistent findings in attention-deficit hyperactivity disorder (ADHD). We reviewed the results of genetic studies
 investigating associations between putative susceptibility genes for ADHD and neuropsychological traits relevant for this
 disorder. A PubMed database search identified 47 studies. Most of them (n&amp;nbsp;=&amp;nbsp;36) examined a single candidate gene, while seven studies examined two or three genes and only four studies examined 10
 genes or more. The most investigated genes were DRD4, DAT1, COMT, MAOA, and DBH. Regarding DRD4, association of high reaction time variability with the 7-R allele absence appears to be...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4610640</comments>
            <pubDate>Wed, 16 Mar 2011 11:54:17 +0100</pubDate>
            <guid isPermaLink="false">4610640</guid>        </item>
        <item>
            <title>The psychosis continuum in the general population: findings from the São Paulo Epidemiologic Catchment Area Study</title>
            <link>http://www.medworm.com/index.php?rid=4610641&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F17714041161226kv%2F</link>
            <description>We described the occurrence of psychotic symptoms, categorized into
 subgroups according to their clinical impact, disability, and help-seeking behavior. The correlation of socio-demographic
 variables, depressive symptoms, and alcohol and substance use disorders with those psychotic subgroups was analyzed. Polychotomic
 logistic regression tested the associations between subgroups of psychosis (clinical and subclinical) and the correlates.
 Of the total sample, 38.0% presented at least one lifetime psychotic symptom, 1.9% met the criteria for an ICD-10 diagnosis
 of non-affective psychosis, 5.4% presented clinically relevant psychotic symptoms, and 30.7% endorsed clinically non-relevant
 symptoms. The most common psychotic symptom was delusion with a plausible explanation (in 18.6%). The ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4610641</comments>
            <pubDate>Tue, 15 Mar 2011 17:26:21 +0100</pubDate>
            <guid isPermaLink="false">4610641</guid>        </item>
        <item>
            <title>Are we going to end up with many distinct genomic syndromes in psychiatry?</title>
            <link>http://www.medworm.com/index.php?rid=4600328&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd276h3072782640m%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-011-0206-6Authors
		Dan Rujescu, Department of Psychiatry, Ludwig-Maximilians-University, Nußbaumstr. 7, 80336 München, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4600328</comments>
            <pubDate>Mon, 14 Mar 2011 16:57:18 +0100</pubDate>
            <guid isPermaLink="false">4600328</guid>        </item>
        <item>
            <title>Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study</title>
            <link>http://www.medworm.com/index.php?rid=4600327&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm00n332136m44127%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Central nervous system (CNS) monoamine deficits have been linked to a number of pathological conditions such as major depressive
 disorder. Individual biological variations in 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenylglycol
 (MHPG) might account for the variation in responses of neurotransmitter systems observed after the administration of clomipramine.
 The prolactin response to clomipramine has been widely used to assess CNS functioning. This open label study investigates
 the prolactin response induced by clomipramine in the plasma of healthy volunteers and whether it is related to changes in
 monoamine metabolites. The effects of clomipramine challenge on prolactin, 5-HIAA, HVA and MHPG were measured in 12 healthy
 vo...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4600327</comments>
            <pubDate>Mon, 14 Mar 2011 16:57:18 +0100</pubDate>
            <guid isPermaLink="false">4600327</guid>        </item>
        <item>
            <title>Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study</title>
            <link>http://www.medworm.com/index.php?rid=4591723&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1w071810g066154%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In a retrospective chart review, we examined the effects of ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist,
 as electroconvulsive therapy (ECT) anaesthetic in patients suffering from therapy-resistant depression. We included 42 patients
 who received ECT treatment with either ketamine (n&amp;nbsp;=&amp;nbsp;16) or the barbiturate thiopental (n&amp;nbsp;=&amp;nbsp;26). We analysed the number of sessions until completion of ECT treatment (used as a surrogate parameter for outcome),
 psychopathology as assessed by pre- and post-ECT Mini-Mental State Examination (MMSE) and Hamilton Rating Scale for Depression
 (HAM-D) scores as well as ECT and seizure parameters (stimulation dose, seizure duration and concordance, urapidil dosage
 for post-seizure blood pressure management). ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4591723</comments>
            <pubDate>Sat, 12 Mar 2011 16:52:42 +0100</pubDate>
            <guid isPermaLink="false">4591723</guid>        </item>
        <item>
            <title>Adult attention deficit hyperactivity disorder is associated with migraine headaches</title>
            <link>http://www.medworm.com/index.php?rid=4580820&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu0qu04334g860x0m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Attention deficit hyperactivity disorder (ADHD) is now recognized as a common disorder both in child and adult psychiatry.
 Adult patients with a diagnosis of ADHD (n&amp;nbsp;=&amp;nbsp;572) and community controls (n&amp;nbsp;=&amp;nbsp;675) responded to auto-questionnaires rating past and present symptoms of ADHD, co-morbid conditions, including migraine,
 treatment history and work status. The prevalence of migraine was significantly higher in the patient group compared to the
 controls (28.3% vs. 19.2%, P&amp;nbsp;&amp;lt;&amp;nbsp;0.001, OR&amp;nbsp;=&amp;nbsp;1.67, CI 1.28–2.17). The difference from controls was particularly marked for men (22.5% vs. 10.7%, P&amp;nbsp;&amp;lt;&amp;nbsp;0.001, OR&amp;nbsp;=&amp;nbsp;2.43, CI 1.51–3.90) but was also significant for women (34.4% vs. 24.9%, P&amp;nbsp;=&amp;nbsp;0.008, OR&amp;nbsp...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4580820</comments>
            <pubDate>Fri, 11 Mar 2011 06:53:08 +0100</pubDate>
            <guid isPermaLink="false">4580820</guid>        </item>
        <item>
            <title>Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?</title>
            <link>http://www.medworm.com/index.php?rid=4565722&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff2v0p57x127312m8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Subjective quality of life (QoL) and psychosocial functioning constitute important treatment outcomes in schizophrenia. We
 aimed to investigate the relationship between them in schizophrenia patients living in the community. Symptom severity and
 insight were assessed with the Positive and Negative Syndrome Scale (PANSS) in 76 community schizophrenia patients. Social
 functioning was measured with the Portuguese version of Personal and Social Performance (PSP) scale, and subjective QoL was
 measured with the Portuguese version of the WHO Quality of Life Measure–Abbreviated Version (WHOQOL–Bref). The majority of
 patients were single (78%) and unemployed/inactive (74%). Mean PSP total score was 55.5, and mean scores on WHOQOL-Bref domains
 ranged from 54.1 to 63.0. ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4565722</comments>
            <pubDate>Mon, 07 Mar 2011 17:03:05 +0100</pubDate>
            <guid isPermaLink="false">4565722</guid>        </item>
        <item>
            <title>Patient’s trust in their psychiatrist: a cross-sectional survey</title>
            <link>http://www.medworm.com/index.php?rid=4549581&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy005651q00867145%2F</link>
            <description>In this study, outpatients who visited one of the participating psychiatric clinics in Tokyo, Japan between
 October and November, 2010 were asked to complete the Trust in Physician Scale (TPS), an 11-item self-report questionnaire.
 A univariate general linear model was used to examine the effects of the following variables on the TPS total score: age,
 sex, diagnosis, Global Assessment of Functioning score, educational background, physician’s years of practice as a psychiatrist,
 duration of treatment with their current psychiatrists, sex concordance between patients and their psychiatrists, and whether
 patients were older than their psychiatrists. Five hundred and four patients were enrolled (mean&amp;nbsp;±&amp;nbsp;SD age&amp;nbsp;=&amp;nbsp;42.8&amp;nbsp;±&amp;nbsp;13.6&amp;nbsp;years;
 176 men; Psychiatri...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4549581</comments>
            <pubDate>Wed, 02 Mar 2011 07:03:38 +0100</pubDate>
            <guid isPermaLink="false">4549581</guid>        </item>
        <item>
            <title>Major depression, borderline personality disorder, and visceral fat content in women</title>
            <link>http://www.medworm.com/index.php?rid=4540384&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F24172n7qg2244783%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Major depressive disorder (MDD) is associated with increased volumes of visceral fat and a high prevalence of the metabolic
 syndrome. In turn, affective disorders are frequently found in patients with borderline personality disorder (BPD). It is
 therefore unclear whether BPD per se may influence body composition. In order to clarify a potential relationship between
 BPD and body composition, we measured visceral fat content (VFC) in young depressed women with and without comorbid BPD and
 related this parameter to various features of the metabolic syndrome. Visceral fat content was measured by magnetic resonance
 imaging in 22 premenopausal women with MDD only, in 44 women with comorbid MDD and BPD, in 12 female BPD patients without
 MDD, and in 34 healthy women (CG)....</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4540384</comments>
            <pubDate>Sat, 26 Feb 2011 15:18:14 +0100</pubDate>
            <guid isPermaLink="false">4540384</guid>        </item>
        <item>
            <title>Prefrontal cortex gyrification index in twins: an MRI study</title>
            <link>http://www.medworm.com/index.php?rid=4512211&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F221gr77712130585%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cortical development and folding seems to be under environmental as well as genetic control. The aim of our study was to estimate
 the genetic influence on gyrification and cortical volumes, comparing prefrontal gyrification index (GI) in monozygotic (MZ)
 and dizygotic (DZ) twin pairs, and unrelated pairs. Twenty-four subjects (6 pairs of MZ and 6 pairs of DZ twins) were included
 in this study. Prefrontal cortical folding (gyrification) was measured by an automated and manual version of the gyrification
 index (A-GI, M-GI) according to previously published protocols. MR-imaging was performed and 3 representative slices were
 selected from coronar MR-imaging scans. The volumes of the total brain, temporal lobes, prefrontal lobes, and cerebellum were
 analyzed, too. To ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4512211</comments>
            <pubDate>Sat, 19 Feb 2011 07:24:36 +0100</pubDate>
            <guid isPermaLink="false">4512211</guid>        </item>
        <item>
            <title>An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses</title>
            <link>http://www.medworm.com/index.php?rid=4501408&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7101507538km1pm8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The presence of comorbidity in major psychoses (e.g., schizophrenia and psychotic subtypes of bipolar disorder and major depressive
 disorder) seems to be the rule rather than the exception in both DSM-IV and ICD-10. Examining comorbidity in major psychoses,
 however, requires an investigation into the different levels of comorbidity (either full-blown and subsyndromal) which should
 be analyzed in both psychopathological and medical fields. On one hand, the high prevalence of psychiatric comorbidity in
 major psychoses may be the result of the current nosographic systems. On the other hand, it may stem from a common neurobiological
 substrate. In fact, comorbid psychopathological conditions may share a biological vulnerability, given that dysfunction in
 specific brain...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4501408</comments>
            <pubDate>Thu, 17 Feb 2011 16:58:56 +0100</pubDate>
            <guid isPermaLink="false">4501408</guid>        </item>
        <item>
            <title>The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction</title>
            <link>http://www.medworm.com/index.php?rid=4501409&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj684w66p42n2525q%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-011-0190-xAuthors
		P. Falkai, Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, GermanyH.-J. Möller, Psychiatry Hospital, Ludwigs-Maximilians-University Munich, Nussbaumstr. 7, 80336, Munich, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4501409</comments>
            <pubDate>Thu, 17 Feb 2011 08:12:03 +0100</pubDate>
            <guid isPermaLink="false">4501409</guid>        </item>
        <item>
            <title>Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes</title>
            <link>http://www.medworm.com/index.php?rid=4501410&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr567418717v87644%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Magnetic resonance imaging and postmortem studies on schizophrenia provided evidence for compromised myelin integrity and
 reduced numbers of oligodendrocytes, which may worsen during the disease course. However, it is not clear whether these findings
 result from disease-inherent oligodendrocyte degeneration or side effects of antipsychotic treatment. Therefore, effects of
 haloperidol and clozapine on the viability and apoptosis of immature oligodendrocytes (OLN-93 cells, immunopositive for NG2,
 Olig1, Olig2) have been evaluated in the present study by labeling with propidium iodide and a caspase 3 assay. Given the
 indications for impaired cerebral energy supply in schizophrenia, a serum and glucose deprivation (SGD) model was chosen in
 comparison with the basal co...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4501410</comments>
            <pubDate>Thu, 17 Feb 2011 08:12:02 +0100</pubDate>
            <guid isPermaLink="false">4501410</guid>        </item>
        <item>
            <title>The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study</title>
            <link>http://www.medworm.com/index.php?rid=4489310&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd4kh001502133j66%2F</link>
            <description>In this study, low-dose
 ω-3 PUFAs had some efficacy in the treatment of mild to moderate depression in elderly participants.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s00406-011-0191-9Authors
		Yaser Tajalizadekhoob, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, 5th floor, Dr Shareeati Hospital, North Karegar Avenue, Tehran, IranFarshad Sharifi, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, 5th floor, Dr Shareeati Hospital, North Karegar Avenue, Tehran, IranHossein Fakhrzadeh, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, 5th floor, Dr Shareeati Hospital, North Karegar Avenue, Tehran, IranMojde Mirarefin, Endocrinology and Metabolism Research Center, Tehran Un...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4489310</comments>
            <pubDate>Mon, 14 Feb 2011 07:12:39 +0100</pubDate>
            <guid isPermaLink="false">4489310</guid>        </item>
        <item>
            <title>Sleep homeostasis in alcohol-dependent, depressed and healthy control men</title>
            <link>http://www.medworm.com/index.php?rid=4470173&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnv08830t8j557485%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Visually scored and power spectral analyses (PSA) of polysomnography (PSG) recordings reveal abnormalities in alcohol dependence
 (AD) and major depressive disorder (MDD), including deficiencies in slow wave activity (SWA) during non-rapid eye movement
 (NREM) sleep. SWA parameters reflect the integrity of the homeostatic sleep drive, which have not been compared in those with
 AD or MDD. Ten men with AD were compared with 10 men with MDD and 10 healthy controls (HCs), all aged 20–40&amp;nbsp;years. They maintained
 an 11&amp;nbsp;pm to 6 am sleep schedule for 5–7&amp;nbsp;days, followed by 3 consecutive nights of PSG in the laboratory: night 1 for adaptation/screening;
 night 2 for baseline recordings; and night 3 as the challenge night, delaying sleep until 2 am. SWA was quan...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4470173</comments>
            <pubDate>Thu, 10 Feb 2011 19:55:57 +0100</pubDate>
            <guid isPermaLink="false">4470173</guid>        </item>
        <item>
            <title>Cerebrospinal fluid diagnostics in first-episode schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=4450079&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3311712022528983%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We evaluated the clinical use and the safety of cerebrospinal fluid diagnostics in 155 patients with the suspected diagnosis
 of first-episode schizophrenia. Five patients (3.2%) revealed pathological findings that lead to diagnostic re-evaluation
 and changes in clinical management. No serious adverse events occurred, but we documented 16 (10.3%) cases of mild to moderate
 headache or local pain at the puncture site. Our results underline the value of lumbar puncture in the clinical workup of
 first-episode patients with suspected schizophrenia.
 
 
	Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-011-0193-7Authors
		Laura Kranaster, Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Ruprecht-Karls-University Heidelberg, J5, 68159 M...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4450079</comments>
            <pubDate>Sat, 05 Feb 2011 16:54:53 +0100</pubDate>
            <guid isPermaLink="false">4450079</guid>        </item>
        <item>
            <title>Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour</title>
            <link>http://www.medworm.com/index.php?rid=4441894&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj6p5q3846h240184%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Suicide and suicidal behaviour are a major health concern worldwide particularly in patients with mood disorders. Family,
 adoption and twin studies show that genetics influences suicidal behaviour. The serotonin transporter (5HTT) plays an important
 role in the pathophysiology of mood disorders and may also be involved in suicidal behaviour since 5HTT binding is decreased
 in the brain of suicide completers. Because the effect of genomic imprinting in the 5HTT gene on suicidal behaviour has not
 been investigated, we analysed the parent-of-origin effect (POE) of four 5HTT markers and the differential expression of the
 5HTT G2651T (rs1042173) alleles in suicide attempters affected by bipolar disorder. We performed a family based association
 study and ETDT/QTDT analys...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4441894</comments>
            <pubDate>Thu, 03 Feb 2011 20:51:24 +0100</pubDate>
            <guid isPermaLink="false">4441894</guid>        </item>
        <item>
            <title>BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects</title>
            <link>http://www.medworm.com/index.php?rid=4441895&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2t48672tpw5284gg%2F</link>
            <description>In this study, we analyzed putative
 correlations in subjects unaffected by mental disorders between personality traits, serum BDNF levels (N&amp;nbsp;=&amp;nbsp;107), and the BDNF Val66Met genotype (N&amp;nbsp;=&amp;nbsp;217). Furthermore, we tested the possible interactions between these variables. A significant correlation has been observed
 between high scores of harm avoidance (HA) measured by the temperament and character inventory (TCI), and low BDNF serum concentration
 (r&amp;nbsp;=&amp;nbsp;−0.253, P&amp;nbsp;=&amp;nbsp;0.009). In addition, an association has been evidenced between low BDNF levels in serum and the BDNF Val/Val genotype (P&amp;nbsp;=&amp;nbsp;0.021). By analyzing putative concomitant effects of different variables on HA scores in a regression model, we observed
 a significant correlation only with BDN...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4441895</comments>
            <pubDate>Thu, 03 Feb 2011 20:51:23 +0100</pubDate>
            <guid isPermaLink="false">4441895</guid>        </item>
        <item>
            <title>Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder</title>
            <link>http://www.medworm.com/index.php?rid=4418882&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl62v708354786348%2F</link>
            <description>This study analyzed brief hypomania
 that occurred in patients with bipolar disorder who were diagnosed according to the DSM-IV criteria. Daily self-reported mood
 ratings were obtained from 393 patients (247 bipolar I and 146 bipolar II) for 6&amp;nbsp;months (75,284&amp;nbsp;days of data, mean 191.6&amp;nbsp;days).
 Episodes of hypomania were calculated using a 4, 3, 2, and single day length criterion. Brief hypomania occurred frequently.
 With a decrease in the minimum criterion from 4&amp;nbsp;days to 2&amp;nbsp;days, there were almost twice as many patients with an episode of
 hypomania (102 vs. 190), and more than twice as many episodes (305 vs. 863). Single days of hypomania were experienced by
 271 (69%) of the sample. With a 2-day episode length, 33% of all hypomania remained outside of an episode. T...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4418882</comments>
            <pubDate>Wed, 26 Jan 2011 19:45:42 +0100</pubDate>
            <guid isPermaLink="false">4418882</guid>        </item>
        <item>
            <title>Excessive cannabis use is associated with earlier age at onset in bipolar disorder</title>
            <link>http://www.medworm.com/index.php?rid=4411401&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F034127gw3537282k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the study was to investigate which factors are associated with age at onset in bipolar disorder with a specific
 focus on excessive alcohol and cannabis use, and the sequence of the onsets of excessive substance use and bipolar disorder.
 We investigated a naturalistic sample of 151 patients with bipolar I and II disorder receiving psychiatric treatment. Whether
 the presence of excessive substance use prior to bipolar disorder onset or the type of substance used (alcohol or cannabis)
 was associated with differences in age at onset was investigated using hierarchical and multiple linear regression analyses,
 adjusting for potential confounders. Patients with excessive alcohol use had a significantly later onset compared with patients
 with excessive cannabis...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4411401</comments>
            <pubDate>Tue, 25 Jan 2011 22:14:43 +0100</pubDate>
            <guid isPermaLink="false">4411401</guid>        </item>
        <item>
            <title>Erratum to: Early-onset bipolar disorder: how about visual-spatial skills and executive functions?</title>
            <link>http://www.medworm.com/index.php?rid=4382492&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F156577q062523785%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00406-010-0180-4Authors
		Sara Lera-Miguel, Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic de Barcelona, Barcelona, SpainSusana Andrés-Perpiñá, Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic de Barcelona, Barcelona, SpainRosa Calvo, Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic de Barcelona, Barcelona, SpainMar Fatjó-Vilas, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Barcelona, SpainLourdes Fañanás, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Barcelona, SpainLuisa Lázaro, Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic de Barcelona, Barcelona, Spain
	

	
		...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4382492</comments>
            <pubDate>Tue, 18 Jan 2011 18:37:40 +0100</pubDate>
            <guid isPermaLink="false">4382492</guid>        </item>
        <item>
            <title>The psychosis continuum: diagnosis and other phenotypes</title>
            <link>http://www.medworm.com/index.php?rid=4377360&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy2148665351634g1%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00406-010-0185-zAuthors
		H. J. Möller, Psychiatrische Klinik der Ludwig-Maximilians-Universität-München, Nußbaumstraße 7, 80336 München, GermanyP. Falkai, Abteilung für Psychiatrie und Psychotherapie, Universität Göttingen, von-Siebold-Straße 5, 37075 Göttingen, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4377360</comments>
            <pubDate>Mon, 17 Jan 2011 20:25:09 +0100</pubDate>
            <guid isPermaLink="false">4377360</guid>        </item>
        <item>
            <title>Cognitive functioning in severe psychiatric disorders: a general population study</title>
            <link>http://www.medworm.com/index.php?rid=4322336&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7vj2q76890470067%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In clinical samples, patients with severe psychiatric disorders are found to have cognitive impairments. Less is known whether
 this applies to samples derived from the general population. We aimed to study cognitive functioning in a population-based
 sample comprising individuals with schizophrenia, other non-affective psychoses, bipolar disorders, major depressive disorder,
 and controls derived from the same population. The current analysis was based on 148 persons with severe mental disorders
 and 66 control subjects, derived from the Psychoses in Finland study. All subjects were interviewed with SCID, and a neuropsychological
 test battery was administered. Subjects with schizophrenia had a generalized cognitive impairment (d&amp;nbsp;=&amp;nbsp;0.43–1.07), while those w...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4322336</comments>
            <pubDate>Wed, 05 Jan 2011 06:45:00 +0100</pubDate>
            <guid isPermaLink="false">4322336</guid>        </item>
        <item>
            <title>A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration</title>
            <link>http://www.medworm.com/index.php?rid=4318127&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvl22604371521x01%2F</link>
            <description>This study presents a visual rating scale for the assessment of cerebral [18F]fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scans to characterize typical findings in dementias associated with frontotemporal
 lobar degeneration (FTLD) and to differentiate individual patients with FTLD compared to Alzheimer’s disease (AD) and mild
 cognitive impairment (MCI). A total of 43 cerebral PET scans from patients with FTLD (n&amp;nbsp;=&amp;nbsp;16, mean age 58.4&amp;nbsp;years), AD (n&amp;nbsp;=&amp;nbsp;16, 59.9&amp;nbsp;years) and MCI (n&amp;nbsp;=&amp;nbsp;11, 57.9&amp;nbsp;years) were analysed. Every PET data set was visually rated for seven brain regions on each hemisphere (frontal
 lobe, temporal lobe, parietal lobe, occipital lobe, basal ganglia, thalamus and cerebellum). The extent of the impairment
 in me...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4318127</comments>
            <pubDate>Tue, 04 Jan 2011 17:50:58 +0100</pubDate>
            <guid isPermaLink="false">4318127</guid>        </item>
        <item>
            <title>Perinatal complications in unaffected sisters of anorexia nervosa patients: testing a covariation model between genetic and environmental factors</title>
            <link>http://www.medworm.com/index.php?rid=4302831&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy0474t6655153qw6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although perinatal complications are hypothesized to be risk factors for the development of anorexia nervosa (AN), no study
 to date explored this issue using a discordant sibling design. This type of design allows to explore whether the risk for
 obstetric complications is itself a consequence of the genetic vulnerability for AN (covariation model) or whether obstetric
 complications increase the risk of AN independently of (additive model), or in interaction with (interaction model), the disorder’s
 genetic liability. The presence of perinatal complications was assessed through review of the obstetric records of 60 AN subjects,
 60 unaffected sisters, and 70 healthy subjects. Unaffected sisters and healthy controls were compared in relation to perinatal
 characteris...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4302831</comments>
            <pubDate>Thu, 30 Dec 2010 18:03:25 +0100</pubDate>
            <guid isPermaLink="false">4302831</guid>        </item>
        <item>
            <title>Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics</title>
            <link>http://www.medworm.com/index.php?rid=4302051&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff86706mv82625t70%2F</link>
            <description>This study reveals
 a pattern of structural alterations in schizophrenia associated with the response to risperidone or olanzapine.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0182-2Authors
		Vicente Molina, Servicio de Psiquiatría, Hospital Universitario de Salamanca, Salamanca, SpainCarmen Martín, Servicio de Psiquiatría, Hospital Universitario de Salamanca, Salamanca, SpainAlejandro Ballesteros, Servicio de Psiquiatría, Hospital Universitario de Salamanca, Salamanca, SpainAlba G. Seco de Herrera, Laboratorio de Imagen Médica, Universidad Rey Juan Carlos, Madrid, SpainJuan Antonio Hernández-Tamames, Laboratorio de Imagen Médica, Universidad Rey Juan Carlos, Madrid, Spain
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4302051</comments>
            <pubDate>Wed, 29 Dec 2010 17:09:31 +0100</pubDate>
            <guid isPermaLink="false">4302051</guid>        </item>
        <item>
            <title>Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry</title>
            <link>http://www.medworm.com/index.php?rid=4302052&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F96q106k156386t6j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gray matter (GM) volume deficits have been described in patients with schizophrenia (Sz) and bipolar disorder (BD), but to
 date, few studies have directly compared GM volumes between these syndromes with methods allowing for whole-brain comparisons.
 We have used structural magnetic resonance imaging (MRI) and voxel-based morphometry (VBM) to compare GM volumes between 38
 Sz and 19 BD chronic patients. We also included 24 healthy controls. The results revealed a widespread cortical (dorsolateral
 and medial prefrontal and precentral) and cerebellar deficit as well as GM deficits in putamen and thalamus in Sz when compared
 to BD patients. Besides, a subcortical GM deficit was shown by Sz and BD groups when compared to the healthy controls, although
 a putaminal reduct...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4302052</comments>
            <pubDate>Tue, 28 Dec 2010 15:03:10 +0100</pubDate>
            <guid isPermaLink="false">4302052</guid>        </item>
        <item>
            <title>Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study</title>
            <link>http://www.medworm.com/index.php?rid=4288452&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl234066gkr0u4j08%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Study aimed to assess clinical and social outcomes following involuntary admissions over 1&amp;nbsp;year and identify socio-demographic
 and clinical patient characteristics associated with more or less favourable outcomes. Seven hundred and seventy-eight involuntary
 patients admitted to one of 22 hospitals in England were assessed within the first week after admission and at 1&amp;nbsp;month, 3&amp;nbsp;month
 and 12&amp;nbsp;month follow-ups. Outcome criteria were symptom levels, global functioning, objective social outcomes, and subjective
 quality of life (SQOL). Baseline characteristics and patients’ initial experience were tested as predictors. Symptom levels
 and global functioning improved moderately. Objective social outcomes showed a small, but statistically significan...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4288452</comments>
            <pubDate>Wed, 22 Dec 2010 20:13:53 +0100</pubDate>
            <guid isPermaLink="false">4288452</guid>        </item>
        <item>
            <title>Expressed and perceived emotion over time: does the patients’ view matter for the caregivers’ burden?</title>
            <link>http://www.medworm.com/index.php?rid=4285040&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6184n610u740358%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;While the impact of mentally ill patients’ perceptions of their key relatives’ expressed emotion is well examined with regard
 to relapse, there is a paucity of evidence concerning the impact on their key relatives’ burden. The present study aims to
 evaluate the relative prognostic value of expressed and perceived emotion on caregivers’ stress outcome within a 3-year follow-up
 period. Yearly follow-up data of the key relatives of 16 first-hospitalized schizophrenic and 34 depressed patients were available
 including expressed and perceived emotion and different dimensions of caregivers’ stress outcome: objective and subjective
 burden, well-being, psychological symptoms and subjective quality of life. Multiple linear regression analyses were computed
 to ass...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4285040</comments>
            <pubDate>Mon, 20 Dec 2010 22:53:26 +0100</pubDate>
            <guid isPermaLink="false">4285040</guid>        </item>
        <item>
            <title>The N1 auditory evoked potential component as an endophenotype for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives, first-episode, and chronic schizophrenia patients</title>
            <link>http://www.medworm.com/index.php?rid=4265185&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc82100njw4r73u62%2F</link>
            <description>This study provides further support for the proposal that the auditory
 N1 deficit in schizophrenia is linked to the underlying genetic risk of developing this disorder. In light of recent studies,
 these results point to the N1 deficit as an endophenotypic marker for schizophrenia. The potential future utility of this
 metric as one element of a multivariate endophenotype is discussed.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0176-0Authors
		John J. Foxe, The Cognitive Neurophysiology Laboratory, Nathan S. Kline Institute for Psychiatric Research, Program in Cognitive Neuroscience and Schizophrenia, 140 Old Orangeburg Road, Orangeburg, NY 10962, USASherlyn Yeap, The Cognitive Neurophysiology Laboratory, St. Vincent’s Hospital, Richmond Road, Fairview, Dublin 3, IrelandAda...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4265185</comments>
            <pubDate>Tue, 14 Dec 2010 06:39:37 +0100</pubDate>
            <guid isPermaLink="false">4265185</guid>        </item>
        <item>
            <title>Obesity and coronary risk in patients treated with second-generation antipsychotics</title>
            <link>http://www.medworm.com/index.php?rid=4265186&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe0txm3l85r77h3g0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Weight gain leading to obesity is a frequent adverse effect of treatment with atypical antipsychotics. However, the degree
 of its independent contribution to the risk of coronary heart disease events in patients treated with these drugs has not
 been elucidated. The aim of this study is to determine whether obesity is an independent risk factor for the 10-year risk
 of coronary heart disease events in psychiatric patients treated with atypical antipsychotics. We used the Framingham method,
 which is based on age, gender, blood pressure, smoking, and plasma levels of total and high-density lipoprotein cholesterol,
 to estimate the 10-year risk of coronary heart disease events in patients treated with second-generation antipsychotics who
 were obese (N&amp;nbsp;=&amp;nbsp;44; me...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4265186</comments>
            <pubDate>Mon, 13 Dec 2010 21:58:18 +0100</pubDate>
            <guid isPermaLink="false">4265186</guid>        </item>
        <item>
            <title>Disgust and implicit self-concept in women with borderline personality disorder and posttraumatic stress disorder</title>
            <link>http://www.medworm.com/index.php?rid=4241512&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1jl134184302235%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Disgust may be a key emotion and target for psychotherapeutic interventions in borderline personality disorder (BPD) and posttraumatic
 stress disorder (PTSD) at explicit and implicit-automatic levels. However, automatically activated disgust reactions in individuals
 with these disorders have not been studied. Disgust and its correlation with childhood abuse were assessed in women with BPD,
 but without PTSD; women with PTSD, but without BPD; women with BPD and PTSD; and healthy women. Disgust sensitivity, anxiety
 and depression were measured by self-report. Implicit disgust-prone (relative to anxiety-prone) self-concept was assessed
 using the Implicit Association Test. Women with BPD and/or PTSD reported more disgust sensitivity than controls. The implicit
 self-con...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4241512</comments>
            <pubDate>Mon, 06 Dec 2010 15:06:37 +0100</pubDate>
            <guid isPermaLink="false">4241512</guid>        </item>
        <item>
            <title>Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas</title>
            <link>http://www.medworm.com/index.php?rid=4241513&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv075u72h1u70m3x6%2F</link>
            <description>We examined charts from 79 patients diagnosed with schizophrenia (n&amp;nbsp;=&amp;nbsp;55), persistent delusional disorders (n&amp;nbsp;=&amp;nbsp;7), and schizoaffective disorders (n&amp;nbsp;=&amp;nbsp;17) between 2003 and 2008. We recorded age, sex, indication for ECT, number of ECT sessions, ECT series, outcome, maintenance
 ECT, use of antipsychotics, duration of illness, and duration of the current exacerbation. All patients were taking antipsychotics
 at the time of enrolment in the study. Acute ECT included 2–26 sessions; maintenance ECT (M-ECT) was given to 18 patients
 for up to 12&amp;nbsp;years. Initial indications for ECT included psychosis (n&amp;nbsp;=&amp;nbsp;28), pronounced affective symptoms (n&amp;nbsp;=&amp;nbsp;28), delirious states (n&amp;nbsp;=&amp;nbsp;20), and M-ECT (n&amp;nbsp;=&amp;nbsp;3). Most patients experienced e...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4241513</comments>
            <pubDate>Mon, 06 Dec 2010 15:06:36 +0100</pubDate>
            <guid isPermaLink="false">4241513</guid>        </item>
        <item>
            <title>The Inventory of Depressive Symptomatology (IDS-C28) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD17) in patients with mild major, minor or subsyndromal depression</title>
            <link>http://www.medworm.com/index.php?rid=4241514&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl0861qk82m202312%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Depression rating scales play a decisive role in the assessment of the severity of depression and the evaluation of the efficacy
 of antidepressant treatments. The Hamilton Depression Rating Scale (HAMD) is regarded as the ‘gold standard’; nevertheless,
 studies suggest that the Inventory of Depressive Symptomatology (IDS) is more sensitive to detect symptom changes. The aim
 of the present study was to investigate whether the IDS is more sensitive in detecting changes in depression symptoms in patients
 with mild major, minor or subsyndromal depression (MIND). Biweekly IDS-C28 and HAMD17 data from 340 patients of a 10-week randomized, placebo-controlled trial comparing the effectiveness of sertraline and cognitive-behavioural
 therapy in patients with MIND were ana...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4241514</comments>
            <pubDate>Mon, 06 Dec 2010 14:44:06 +0100</pubDate>
            <guid isPermaLink="false">4241514</guid>        </item>
        <item>
            <title>Erratum to: The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey</title>
            <link>http://www.medworm.com/index.php?rid=4207220&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm8422104np7n5044%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00406-010-0171-5Authors
		M. K. Yazıcı, Department of Psychiatry, Hacettepe University Faculty of Medicine, 06100 Ankara, TurkeyA. E. Anıl Yağcıoğlu, Department of Psychiatry, Hacettepe University Faculty of Medicine, 06100 Ankara, TurkeyA. Ertuğrul, Department of Psychiatry, Hacettepe University Faculty of Medicine, 06100 Ankara, TurkeyN. Eni, Department of Psychiatry, Hacettepe University Faculty of Medicine, 06100 Ankara, TurkeyS. Karahan, Department of Biostatistics, Hacettepe University Faculty of Medicine, 06100 Ankara, TurkeyE. Karaağaoğlu, Department of Biostatistics, Hacettepe University Faculty of Medicine, 06100 Ankara, TurkeyS. L. Tokgözoğlu, Department of Cardiology, Hacettepe University Faculty of Medicine, 06100 Ankara, T...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4207220</comments>
            <pubDate>Fri, 26 Nov 2010 18:05:06 +0100</pubDate>
            <guid isPermaLink="false">4207220</guid>        </item>
        <item>
            <title>A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia</title>
            <link>http://www.medworm.com/index.php?rid=4207219&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw6j216u58q44h541%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Agoraphobia (with and without panic disorder) is a highly prevalent and disabling anxiety disorder. Its neural complexity
 can be characterized by specific cues in fMRI studies. Therefore, we developed a fMRI paradigm with agoraphobia-specific stimuli.
 Pictures of potential agoraphobic situations were generated. Twenty-six patients, suffering from panic disorder and agoraphobia,
 and 22 healthy controls rated the pictures with respect to arousal, valence, and agoraphobia-related anxiety. The 96 pictures,
 which discriminated best between groups were chosen, split into two parallel sets and supplemented with matched neutral pictures
 from the International Affective Picture System. Reliability, criterion, and construct validity of the picture set were determined
 in a s...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4207219</comments>
            <pubDate>Fri, 26 Nov 2010 18:05:06 +0100</pubDate>
            <guid isPermaLink="false">4207219</guid>        </item>
        <item>
            <title>Sleep, hypothalamus, and stigma</title>
            <link>http://www.medworm.com/index.php?rid=4203037&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe6104r28j1w52614%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00406-010-0170-6Authors
		Peter Falkai, Department of Psychiatry und Psychotherapy, University of Göttingen, von-Siebold-Str. 5, 37075 Göttingen, GermanyHans-Jürgen Möller, Psychiatry Hospital, Ludwig-Maximilians-University Munich, Nussbaumstr. 7, 80336 München, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4203037</comments>
            <pubDate>Wed, 24 Nov 2010 18:51:36 +0100</pubDate>
            <guid isPermaLink="false">4203037</guid>        </item>
        <item>
            <title>Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD</title>
            <link>http://www.medworm.com/index.php?rid=4196815&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb61605k72524g717%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adrenergic α2A receptor gene (ADRA2A) is one of the most promising candidate genes for ADHD pharmacogenetics. Thus far, three studies have investigated the association
 between the ADRA2A −1291 C&amp;gt;G polymorphism and the therapeutic response to methylphenidate (MPH) in children with ADHD, all of them with positive
 results. The aim of this study is to investigate, for the first time, the association between three ADRA2A polymorphisms (−1291 C&amp;gt;G, −262 G&amp;gt;A, and 1780 C&amp;gt;T) and the response to MPH in adults with ADHD. The sample comprises 165 Brazilians
 of European descent evaluated in the adult ADHD outpatient clinic of the Hospital de Clínicas de Porto Alegre. The diagnostic
 procedures followed the DSM-IV criteria. Drug response was assessed by both cat...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4196815</comments>
            <pubDate>Sat, 20 Nov 2010 06:56:03 +0100</pubDate>
            <guid isPermaLink="false">4196815</guid>        </item>
        <item>
            <title>Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=4189941&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F462x8065t44046r8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;On the basis of impaired glutamatergic transmission and the potential role of astrocytes in schizophrenia, we treated cultured
 astrocytes with MK-801, an NMDA-receptor antagonist, to investigate whether the resulting proteome changes are similar to
 those we found in our earlier proteome analysis of schizophrenia human brain tissue as well as to better comprehend the role
 of astrocytes in the disorder. Indeed, there are similarities. Furthermore, to verify the efficacy of clozapine and its effect
 over the proteome, we treated MK-801-treated astrocytes with clozapine. Interestingly, clozapine reversed protein changes
 induced by MK-801. The treatment of cell cultures with neural transmission agonists and antagonists might provide useful insights
 about psychiatric dis...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4189941</comments>
            <pubDate>Fri, 19 Nov 2010 07:27:23 +0100</pubDate>
            <guid isPermaLink="false">4189941</guid>        </item>
        <item>
            <title>Early-onset bipolar disorder: how about visual-spatial skills and executive functions?</title>
            <link>http://www.medworm.com/index.php?rid=4186820&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F05008177vwp10w14%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp; Early-onset bipolar disorder is an impairing condition that is strongly associated with genetic inheritance. Neurocognitive
 deficits are core traits of this disorder which seem to be present in both young and adult forms. Deficits in verbal memory
 and attention are persistent within euthymic phases in bipolar adults, adolescents, and children. In younger samples, including
 type I or II and not otherwise specified patients, executive functions are not widely impaired and the existence of visual-spatial
 deficits remains unclear. The main aim of this study was to compare the neurocognitive performance in young stabilized type
 I or II bipolar patients and healthy controls. Fifteen medicated adolescents with bipolar disorder and 15 healthy adolescents,
 matched in age ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4186820</comments>
            <pubDate>Thu, 18 Nov 2010 07:56:13 +0100</pubDate>
            <guid isPermaLink="false">4186820</guid>        </item>
        <item>
            <title>Erratum to: Dysfunctional pain modulation in somatoform pain disorder patients</title>
            <link>http://www.medworm.com/index.php?rid=4175466&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F28p5423771g6g466%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00406-010-0168-0Authors
		Stefanie Klug, Department of Psychiatry and Psychotherapy, General Hospital of Vienna, Medical University of Vienna, Wa¨hringer-Gu¨rtel 18-20, 1090 Vienna, AustriaPeter Anderer, Department of Psychiatry and Psychotherapy, General Hospital of Vienna, Medical University of Vienna, Wa¨hringer-Gu¨rtel 18-20, 1090 Vienna, AustriaGerda Saletu-Zyhlarz, Department of Psychiatry and Psychotherapy, General Hospital of Vienna, Medical University of Vienna, Wa¨hringer-Gu¨rtel 18-20, 1090 Vienna, AustriaMarion Freidl, Department of Psychiatry and Psychotherapy, General Hospital of Vienna, Medical University of Vienna, Wa¨hringer-Gu¨rtel 18-20, 1090 Vienna, AustriaBernd Saletu, Department of Psychiatry and Psychotherapy, Genera...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4175466</comments>
            <pubDate>Sat, 13 Nov 2010 06:45:27 +0100</pubDate>
            <guid isPermaLink="false">4175466</guid>        </item>
        <item>
            <title>A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression</title>
            <link>http://www.medworm.com/index.php?rid=4162760&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr5vn65hr7r6x6144%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Verbal and visuospatial working memory (WM) impairment is a well-documented finding in psychiatric patients suffering from
 major psychoses such as schizophrenia or bipolar affective disorder. However, in major depression (MDD) the literature on
 the presence and the extent of WM deficits is inconsistent. The use of a multitude of different WM tasks most of which lack
 process-specificity may have contributed to these inconsistencies. Eighteen MDD patients and 18 healthy controls matched with
 regard to age, gender and education were tested using process- and circuit-specific WM tasks for which clear brain-behaviour
 relationships had been established in prior functional neuroimaging studies. Patients suffering from acute MDD showed a selective
 impairment in articulato...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4162760</comments>
            <pubDate>Wed, 10 Nov 2010 10:51:32 +0100</pubDate>
            <guid isPermaLink="false">4162760</guid>        </item>
        <item>
            <title>The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients</title>
            <link>http://www.medworm.com/index.php?rid=4142588&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4101170k03h77170%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the present study, we examined several metabolic parameters in a group of 19 acutely depressed inpatients with major depression
 (DSM-IV) at baseline and investigated their development after 4&amp;nbsp;weeks of antidepressant treatment with reboxetine (8–12&amp;nbsp;mg
 per day). We performed oral glucose tolerance tests and additionally assessed free saliva cortisol and post-dexamethasone
 cortisol levels, as well as whole cholesterol, HDL- and LDL-cholesterol, triglycerides, free fatty acids, waist and hip circumference,
 heart rate, systolic and diastolic blood pressure. Furthermore, we evaluated the incidence of a metabolic syndrome and investigated
 the metabolic changes in depressed patients with and without a metabolic syndrome. We found 42.1% of patients to fulfil ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4142588</comments>
            <pubDate>Fri, 05 Nov 2010 10:51:47 +0100</pubDate>
            <guid isPermaLink="false">4142588</guid>        </item>
        <item>
            <title>Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade</title>
            <link>http://www.medworm.com/index.php?rid=4097254&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F80184x6835n7r844%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The cholinergic system is essential in mediating cognitive processes. Although there has been extensive research regarding
 cholinergic receptor subsystems, the specific contribution of the muscarinic and nicotinic receptor system to cognitive processes
 still has not been sufficiently explored. In the present study, we examined the selective contribution of muscarinic and nicotinic
 antagonism to cognitive performance in healthy human subjects. A single-blind, double-dummy, time-elapsed, repeated measures
 cross-over design was used on 15 healthy males. Subjects completed a neuropsychological test battery assessing a wide range
 of cognitive domains after 0.4&amp;nbsp;mg scopolamine (intravenous), 0.2&amp;nbsp;mg/kg mecamylamine (max. 15&amp;nbsp;mg; oral) or placebo. Subjects
 we...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097254</comments>
            <pubDate>Wed, 20 Oct 2010 12:01:04 +0100</pubDate>
            <guid isPermaLink="false">4097254</guid>        </item>
        <item>
            <title>Anticholinergic drug use and risk for dementia: target for dementia prevention</title>
            <link>http://www.medworm.com/index.php?rid=4097253&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq3596v2j14q829l3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An increasing number of longitudinal cohort studies have identified a risk increase for dementia by the chronic use of drugs
 with anticholinergic properties. The respective data from the German Study on Aging, Cognition and Dementia in Primary Care
 Patients (AgeCoDe) also showing risk increase (hazard ratio&amp;nbsp;=&amp;nbsp;2.081) are reported here. The mechanisms by which the risk increase
 is transported are still unknown. Irritation of compensated alterations of cholinergic transmission at the pre-dementia stage
 of Alzheimer’s disease (AD) or acceleration of neuroinflammation by disturbance of the anti-inflammatory effect of cholinergic
 innervation are discussed. In terms of dementia prevention, centrally acting anticholinergic drugs should be strictly avoided,
 bec...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097253</comments>
            <pubDate>Wed, 20 Oct 2010 12:01:04 +0100</pubDate>
            <guid isPermaLink="false">4097253</guid>        </item>
        <item>
            <title>Psychiatric illness through the lifespan</title>
            <link>http://www.medworm.com/index.php?rid=4097256&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp413101322633602%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00406-010-0163-5Authors
		Frank Schneider, Department of Psychiatry and Psychotherapy, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, GermanyMichael Grözinger, Department of Psychiatry and Psychotherapy, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097256</comments>
            <pubDate>Wed, 20 Oct 2010 12:01:03 +0100</pubDate>
            <guid isPermaLink="false">4097256</guid>        </item>
        <item>
            <title>Altered amygdala functional connectivity in adult Tourette’s syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4097255&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp41485u3m2252124%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tourette’s syndrome (TS) is a developmental neuropsychiatric disorder characterized by motor and vocal tics as well as psychiatric
 comorbidities. Recently, differences in maturation of cortical networks using functional connectivity metrics have been described
 for this disorder. However, adult data on subcortical networks are scarce. In particular, the connectivity of the amygdala,
 for which a role in the pathophysiology of TS has been established, has not been examined so far. We studied 15 adult TS patients
 (11 male, aged 30.4&amp;nbsp;±&amp;nbsp;9.7y) and 15 age- and sex-matched controls (11 male, aged 32.0&amp;nbsp;±&amp;nbsp;9.3y) in a functional magnetic resonance
 imaging study at 1.5T using a simple motor task. We corrected for possible confounds introduced by tics, mot...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097255</comments>
            <pubDate>Wed, 20 Oct 2010 12:01:03 +0100</pubDate>
            <guid isPermaLink="false">4097255</guid>        </item>
        <item>
            <title>Ethics in psychiatry: the lessons we learn from Nazi psychiatry</title>
            <link>http://www.medworm.com/index.php?rid=4097257&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj1365w2554220664%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Under the Euthanasia Program of Nazi Germany, more than 200,000 psychiatric patients were killed by doctors in psychiatric
 institutions. After summarising the historical facts and the slow and still going-on process of illuminating and understanding
 what happened, some ethical consequences are drawn. What can we learn from history? The following aspects are addressed: the
 special situation of psychiatry in times of war, bioethics and biopolitics, the responsibility of the psychiatrist for the
 individual patient, the effects of hierarchy on personal conscience and responsibility, the unethical “curable-uncurable”
 distinction and the atrocious concept that persons differ in their value.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0158-2Authors
		Micha...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097257</comments>
            <pubDate>Tue, 19 Oct 2010 23:51:05 +0100</pubDate>
            <guid isPermaLink="false">4097257</guid>        </item>
        <item>
            <title>Is there a personalized medicine for mood disorders?</title>
            <link>http://www.medworm.com/index.php?rid=4097258&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6176pmu0576u5055%2F</link>
            <description>This article will further cover the current state of peripheral and neural
 biomarker research.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0152-8Authors
		Lucie Bartova, Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, AustriaAndreas Berger, Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, AustriaLukas Pezawas, Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097258</comments>
            <pubDate>Tue, 19 Oct 2010 19:26:47 +0100</pubDate>
            <guid isPermaLink="false">4097258</guid>        </item>
        <item>
            <title>Individualised treatment in alcohol-dependent patients</title>
            <link>http://www.medworm.com/index.php?rid=4097259&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgl47272442260424%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Long-term relapse prevention is the biggest challenge in treating alcohol-dependent patients. It is equally based on psychotherapy
 and pharmacotherapy. Psychotherapy includes motivational interviewing, community reinforcement, cognitive behavioural therapy,
 motivational enhancement, twelve-step facilitation, social network behaviour therapy, cue exposure, etc. For pharmacological
 treatment, we dispose of disulfiram, acamprosate and naltrexone. Reviews and meta-analyses reveal only modest effect sizes
 of these approaches probably because they are usually tested in large and heterogeneous samples where “one size does not fit
 all”. However, attempts to form more homogeneous subgroups for which specific psychotherapies should be more effective (“matching”)
 als...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4097259</comments>
            <pubDate>Sat, 16 Oct 2010 08:35:33 +0100</pubDate>
            <guid isPermaLink="false">4097259</guid>        </item>
        <item>
            <title>Intervention in at-risk states for developing psychosis</title>
            <link>http://www.medworm.com/index.php?rid=4086078&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl14l735uj4682748%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Indicated prevention is currently one of the most promising approaches to fight the individual and societal burden associated
 with psychosis and particularly schizophrenia. The number of studies is still limited, yet encouraging results have been reported
 from pharmacological and psychotherapeutic trials. Furthermore, it has become clear that persons characterized by the at-risk
 criteria are already ill and do not only need preventive intervention but also treatment. As is indicated by a recent study
 successfully using omega-3 fatty acids for both purposes, it may be promising to develop and investigate interventions especially
 for the at-risk state, independent of their effectiveness in manifest disease states. An overview on the current findings
 and ongoing rese...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4086078</comments>
            <pubDate>Fri, 15 Oct 2010 17:35:47 +0100</pubDate>
            <guid isPermaLink="false">4086078</guid>        </item>
        <item>
            <title>State of psychiatry in Germany</title>
            <link>http://www.medworm.com/index.php?rid=4073687&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F374jxwhp82j8n630%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Psychiatry in Germany is characterized by high relevance both individually and socioeconomically, and by the burden caused
 by mental disorders as lifelong diseases. This is comparable to most industrialized countries in the world. For Germany, the
 role of psychiatry in Nazi-Germany has to be critically discussed and still remains incompletely researched. Another more
 current focus has to be directed to attracting the most promising young students to the discipline. Psychiatry promises to
 profit especially from new approaches that combine scientific and clinical expertise in education and professional career.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0162-6Authors
		F. Schneider, Department of Psychiatry and Psychotherapy, RWTH Aachen University, Pauwel...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4073687</comments>
            <pubDate>Thu, 14 Oct 2010 06:11:56 +0100</pubDate>
            <guid isPermaLink="false">4073687</guid>        </item>
        <item>
            <title>Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=4073686&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbw94214335016183%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Obstetric complications play a role in the pathophysiology of schizophrenia. However, the biological consequences during neurodevelopment
 until adulthood are unknown. Microarrays have been used for expression profiling in four brain regions of a rat model of neonatal
 hypoxia as a common factor of obstetric complications. Animals were repeatedly exposed to chronic hypoxia from postnatal (PD)
 day 4 through day 8 and killed at the age of 150&amp;nbsp;days. Additional groups of rats were treated with clozapine from PD 120–150.
 Self-spotted chips containing 340 cDNAs related to the glutamate system (“glutamate chips”) were used. The data show differential
 (up and down) regulations of numerous genes in frontal (FR), temporal (TE) and parietal cortex (PAR), and in cauda...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4073686</comments>
            <pubDate>Thu, 14 Oct 2010 06:11:56 +0100</pubDate>
            <guid isPermaLink="false">4073686</guid>        </item>
        <item>
            <title>Ethical guidelines in psychiatric research</title>
            <link>http://www.medworm.com/index.php?rid=4073688&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F82077w0v758v6l6x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Capacity to consent is a basic prerequisite for participation of patients as probands in research. However, mental illness
 often impairs this competence. Therefore, in psychiatric research, the first obligation is to assess a mentally ill patient’s
 competence to consent. This is not a simple task. Informed consent should be viewed not only as a legal must, but also as
 a chance to build up a trusting patient–psychiatrist relationship. This is called for by respect for the autonomy and dignity
 of the patient. Specifically, competence to consent is related to the specific intervention; the validity of a consent requires
 that the patient understands the intervention-related medical information, comprehends its significance and consequences,
 and can appreciate its ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4073688</comments>
            <pubDate>Tue, 12 Oct 2010 06:45:59 +0100</pubDate>
            <guid isPermaLink="false">4073688</guid>        </item>
        <item>
            <title>Fascination violence: on mind and brain of man hunters</title>
            <link>http://www.medworm.com/index.php?rid=4073689&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd513q1502k6u170u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Why are savagery and violence so omnipresent among humans? We suggest that hunting behaviour is fascinating and attractive,
 a desire that makes temporary deprivation from physical needs, pain, sweat, blood and, ultimately, the willingness to kill
 tolerable and even appetitive. Evolutionary development into the “perversion” of the urge to hunt humans, that is to say the
 transfer of this hunt to members of one’s own species, has been nurtured by the resultant advantage of personal and social
 power and dominance. While a breakdown of the inhibition towards intra-specific killing would endanger any animal species,
 controlled inhibition was enabled in humans in that higher regulatory systems, such as frontal lobe-based executive functions,
 prevent the involuntary...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4073689</comments>
            <pubDate>Mon, 11 Oct 2010 16:46:19 +0100</pubDate>
            <guid isPermaLink="false">4073689</guid>        </item>
        <item>
            <title>Financial and non-financial conflicts of interests in psychiatry</title>
            <link>http://www.medworm.com/index.php?rid=4053221&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1304w2l5367vm166%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A conflict of interests occurs when a doctor is unduly influenced by a secondary interest (i.e., a personal incentive) in
 his acts concerning one of the primary interests to which he is professionally committed (the welfare of patients, the progress
 of science, or the education of students or residents). One specific variety of conflicts of interests has monopolized the
 attention of the scientific and lay press: the financial conflicts of interests arising from the relationships between doctors
 and drug companies. A large literature has described the many, sometimes subtle, ways by which a psychiatrist can be influenced
 in his prescribing habits or research activities by his relationships with the industry. Some empirical evidence is now available
 in this area. On...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053221</comments>
            <pubDate>Fri, 08 Oct 2010 17:03:16 +0100</pubDate>
            <guid isPermaLink="false">4053221</guid>        </item>
        <item>
            <title>Psychopathic disorders and criminal responsibility in the USA</title>
            <link>http://www.medworm.com/index.php?rid=4053223&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff912w01870tl7873%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The insanity defense in the United States is available to provide a legal excuse for those whose criminal acts were due to
 serious mental illness. To an underappreciated extent, the evolution of the insanity defense is integrally related to the
 evolution of conceptions of psychopathic disorders and their relevance, or determined lack thereof, to the insanity defense.
 As legal and mental health professionals discuss the ideal insanity defense and whether psychopathic disorders should be qualifying
 or disqualifying conditions, any practical outcome of such discussions must take into account the politics of the insanity
 defense. When this is done, it becomes apparent that the insanity defense itself, even for serious, psychotic mental disorders,
 is withering under re...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053223</comments>
            <pubDate>Fri, 08 Oct 2010 17:03:12 +0100</pubDate>
            <guid isPermaLink="false">4053223</guid>        </item>
        <item>
            <title>Social reinforcement can regulate localized brain activity</title>
            <link>http://www.medworm.com/index.php?rid=4053222&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp123lg1v8501g272%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Social learning is essential for adaptive behavior in humans. Neurofeedback based on functional magnetic resonance imaging
 (fMRI) trains control over localized brain activity. It can disentangle learning processes at the neural level and thus investigate
 the mechanisms of operant conditioning with explicit social reinforcers. In a pilot study, a computer-generated face provided
 a positive feedback (smiling) when activity in the anterior cingulate cortex (ACC) increased and gradually returned to a neutral
 expression when the activity dropped. One female volunteer without previous experience in fMRI underwent training based on
 a social reinforcer. Directly before and after the neurofeedback runs, neural responses to a cognitive interference task (Simon
 task) were re...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053222</comments>
            <pubDate>Fri, 08 Oct 2010 17:03:12 +0100</pubDate>
            <guid isPermaLink="false">4053222</guid>        </item>
        <item>
            <title>Therapy-refractory panic: current research areas as possible perspectives in the treatment of anxiety</title>
            <link>http://www.medworm.com/index.php?rid=4053224&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn3w65lx7816h2706%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Panic disorder (PD) is characterized by recurrent panic attacks that are defined as distinct episodes of intense fear, accompanied
 by symptoms related to physical arousal. Because most patients interpret these symptoms as signs of serious somatic disease
 (e.g., a heart attack), utilization of healthcare services is high in PD sufferers. PD can become debilitating, interfering
 significantly with patients’ lives. Fortunately, effective treatments are available, but a considerable proportion of patients
 do not respond sufficiently. The aim of this paper is to outline some promising research strategies aimed at improving established
 treatments.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0143-9Authors
		J. Diemer, Mood and Anxiety Research Unit, Departmen...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053224</comments>
            <pubDate>Fri, 08 Oct 2010 17:03:08 +0100</pubDate>
            <guid isPermaLink="false">4053224</guid>        </item>
        <item>
            <title>Dysfunctional pain modulation in somatoform pain disorder patients</title>
            <link>http://www.medworm.com/index.php?rid=4044845&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu0430j353j00h118%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To date, pain perception is thought to be a creative process of modulation carried out by an interplay of pro- and anti-nociceptive
 mechanisms. Recent research demonstrates that pain experience constitutes the result of top–down processes represented in
 cortical descending pain modulation. Cortical, mainly medial and frontal areas, as well as subcortical structures such as
 the brain stem, medulla and thalamus seem to be key players in pain modulation. An imbalance of pro- and anti-nociceptive
 mechanisms are assumed to cause chronic pain disorders, which are associated with spontaneous pain perception without physiologic
 scaffolding or exaggerated cortical activation in response to pain exposure. In contrast to recent investigations, the aim
 of the present study ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4044845</comments>
            <pubDate>Wed, 06 Oct 2010 06:00:14 +0100</pubDate>
            <guid isPermaLink="false">4044845</guid>        </item>
        <item>
            <title>Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy</title>
            <link>http://www.medworm.com/index.php?rid=4036354&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe72708890p7u377r%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00406-010-0154-6Authors
		P. Falkai, Department of Psychiatry und Psychotherapy, University of Göttingen, von-Siebold-Str. 5, 37075 Göttingen, GermanyH.-J. Möller, Psychiatry Hospital, Ludwigs-Maximilians-University Munich, Nussbaumstr. 7, 80336 Munich, Germany
	

	
		Journal European Archives of Psychiatry and Clinical NeuroscienceOnline ISSN 1433-8491Print ISSN 0940-1334 (Source: European Archives of Psychiatry and Clinical Neuroscience)</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4036354</comments>
            <pubDate>Mon, 04 Oct 2010 13:19:25 +0100</pubDate>
            <guid isPermaLink="false">4036354</guid>        </item>
        <item>
            <title>Personality factors and mental health outcome in caregivers of first hospitalized schizophrenic and depressed patients: 2-year follow-up results</title>
            <link>http://www.medworm.com/index.php?rid=4022510&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe5402782n3p67390%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;While neuroticism has been intensely investigated in caregivers of patients with serious somatic disorders, studies in caregivers
 of patients with mental illness are lacking. Additionally, most studies are cross-sectional not allowing conclusions about
 long-term effects of personality factors. The present study examines the impact of personality factors on the course of subjective
 burden and psychological well-being by a mediational model in a sample of caregivers of first hospitalized patients with schizophrenia
 or depression within a 2-year follow-up period. At baseline, 83 caregivers could be enrolled in the study, the drop-out rate
 was about 23% at 2-year follow-up. Personality factors were assessed by the German version of the NEO-FFI (Borstenau and Costa
 199...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4022510</comments>
            <pubDate>Wed, 29 Sep 2010 05:44:44 +0100</pubDate>
            <guid isPermaLink="false">4022510</guid>        </item>
        <item>
            <title>ADC changes in schizophrenia: a diffusion-weighted imaging study</title>
            <link>http://www.medworm.com/index.php?rid=4012711&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj1p36k3rl4v33373%2F</link>
            <description>In this study, we assessed
 ADC in 18 patients with schizophrenia and 18 healthy controls using a voxel-based approach. We did not find evidence of statistically
 significant changes in ADC in either direction at P&amp;nbsp;&amp;lt;&amp;nbsp;0.05 (FDR corrected) using different smoothing filter sizes; only at an uncorrected threshold of P&amp;nbsp;&amp;lt;&amp;nbsp;0.001 did we find an increase in a small right prefrontal area close to our previous FA finding. Our findings therefore
 do not support ADC changes to be a marker of white matter or grey matter abnormalities in schizophrenia. Changes in other
 parameters like fractional anisotropy (FA) might be a more sensitive indicator of white matter pathology in this disorder.
 
 
	Content Type Journal ArticleDOI 10.1007/s00406-010-0150-xAuthors
		Igor Nenadic, Dep...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4012711</comments>
            <pubDate>Sat, 25 Sep 2010 16:58:17 +0100</pubDate>
            <guid isPermaLink="false">4012711</guid>        </item>
        <item>
            <title>Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram</title>
            <link>http://www.medworm.com/index.php?rid=3998683&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd1g1111u045628m3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The purpose of this analysis was to explore the potential role of anxious MDD as a treatment predictor and moderator in major
 depressive disorder (MDD) using a large escitalopram clinical trial dataset. Individual patient-level data from 13 double-blinded,
 randomized, controlled trials in patients with MDD were pooled. Both univariate, last observation carried forward (LOCF) analyses
 and repeated measurements analyses without imputation (MMRM) were carried out for change in symptom scores, response and remission
 rates. Of 3,919 patients, 48.0% were classified as having anxious MDD depression (HAMD) somatization/anxiety subscale score
 ≥7 at baseline. Patients with anxious MDD were less likely to report symptom improvement on some outcome measures than patients
 wi...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3998683</comments>
            <pubDate>Wed, 22 Sep 2010 05:49:51 +0100</pubDate>
            <guid isPermaLink="false">3998683</guid>        </item>
        <item>
            <title>Considerations for analysis of source monitoring data when investigating hallucinations in schizophrenia research</title>
            <link>http://www.medworm.com/index.php?rid=3980548&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7705236k17136012%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Self/other (i.e., internal/external) source monitoring is one of the leading paradigms for the study of hallucinations in
 schizophrenia. The cognitive processes that underlie hallucinations are theorized to transform self-generated (internal) cognitive
 events into other-generated (external) cognitive events. These proposed cognitive operations also appear to play a role in
 producing analogous types of errors in self/other source monitoring, namely a memory bias whereby recalled material that was
 self-generated is misremembered as other-generated, referred to as an externalization bias. Externalization biases are more frequent in groups of hallucinating schizophrenia patients than in other groups. One source
 of measurement error that is inherent in the study of the ...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3980548</comments>
            <pubDate>Thu, 16 Sep 2010 16:46:35 +0100</pubDate>
            <guid isPermaLink="false">3980548</guid>        </item>
        <item>
            <title>Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis</title>
            <link>http://www.medworm.com/index.php?rid=3980549&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn4544637818x3144%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The self-medication hypothesis attempts to explain the extraordinary high levels of cigarette smoking in schizophrenia; patients
 may smoke in an attempt to reduce their cognitive deficits, symptoms, or the side effects of antipsychotics. In a previous
 report, we detected beneficial performance in attention and working memory in patients with first-episode psychosis who smoked
 compared to non-smoking patients soon after stabilization. In the present study, we examine differences in the course of those
 deficits 12&amp;nbsp;months after the initiation of antipsychotic treatment. We also explore the association between smoking and symptoms
 and side effects of medication. Neuropsychological assessments were performed at baseline, month 6 and month 12 using a computerized
 b...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3980549</comments>
            <pubDate>Tue, 14 Sep 2010 05:57:13 +0100</pubDate>
            <guid isPermaLink="false">3980549</guid>        </item>
        <item>
            <title>Severity of alcohol-related problems and mortality: results from a 20-year prospective epidemiological community study</title>
            <link>http://www.medworm.com/index.php?rid=3968857&amp;cid=s_33413_168_f&amp;fid=33413&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq86255u174965133%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is evidence that high alcohol use is associated with an increase in mortality. Little is known about long-term effects
 of problematic alcohol consumption in non-clinical (community) populations. The aim of our study was to obtain data on this and related issues in a representative rural community sample assessed longitudinally over a period of 20&amp;nbsp;years. Assessments focused on a baseline survey from 1980 to 1984 and 20-year
 follow-up from 2001 to 2004. Based on expert interviews and standardized self-rating scales (e.g. MALT; Munich Alcoholism
 Test), the following three groups were defined (a) severe
 alcohol problems, (b) moderate alcohol problems, and (c) no alcohol problems. Mortality and hazard rates were analyzed with logistic and Cox regression adjust...</description>
            <author>European Archives of Psychiatry and Clinical Neuroscience</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3968857</comments>
            <pubDate>Mon, 13 Sep 2010 17:01:24 +0100</pubDate>
            <guid isPermaLink="false">3968857</guid>        </item>
    </channel>
</rss>

